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Photoacoustic (PA) imaging is a rapidly emerging non-invasive soft tissue imaging modality 
which has the potential to detect tissue abnormality at early stage. Photoacoustic images map the 
spatially varying optical absorption property of tissue. In multiwavelength photoacoustic 
imaging, the soft tissue is imaged with different wavelengths, tuned to the absorption peaks of 
the specific light absorbing tissue constituents or chromophores to obtain images with different 
contrasts of the same tissue sample. From those images, spatially varying concentration of the 
chromophores can be recovered. As multiwavelength PA images can provide important 
physiological information related to function and molecular composition of the tissue, so they 
can be used for diagnosis of cancer lesions and differentiation of malignant tumors from benign 
tumors.  
 In this research, a number of parameters have been extracted from multiwavelength 3D PA 
images of freshly excised human prostate and thyroid specimens, imaged at five different 
wavelengths. Using marked histology slides as ground truths, region of interests (ROI) 
corresponding to cancer, benign and normal regions have been identified in the PA images. The 
extracted parameters belong to different categories namely chromophore concentration, 
frequency parameters and PA image pixels and they represent different physiological and optical 
properties of the tissue specimens. Statistical analysis has been performed to test whether the 
extracted parameters are significantly different between cancer, benign and normal regions. A 
multidimensional [29 dimensional] feature set, built with the extracted parameters from the 3D 
PA images, has been divided randomly into training and testing sets. The training set has been 
used to train support vector machine (SVM) and neural network (NN) classifiers while the 
performance of the classifiers in differentiating different tissue pathologies have been determined 
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by the testing dataset. Using the NN classifier, performance of parameters belonging to different 
categories in differentiating malignant tissue from nonmalignant tissue has been determined. It 
has been found that, among different categories, the frequency parameters performed best in 
differentiating malignant from nonmalignant tissue [sensitivity and specificity with testing 
dataset are 85% and 84%] while performance of all the categories combined was better than that 
[sensitivity and specificity with testing dataset are 93% and 91%]. 
However, PA imaging cannot be used to provide the anatomical cues required to determine the 
position of the detected or suspected malignant tumor region relative to familiar organ 
landmarks. On the other hand, although accuracy of Ultrasound (US) imaging in detecting cancer 
lesions is low, major anatomical cues like organ boundaries or presence of nearby major organs 
are visible in US images. A dual mode PA and US imaging system can potentially detect as well 
as localize cancer lesions with high accuracy. In this study, we have developed a novel pulse 
echo US imaging system which can be easily integrated with our existing ex-vivo PA imaging 
system to produce the dual mode imaging system. Here a Polyvinylidene fluoride (PVDF) film 
has been used as US transmitter. To improve the anticipated low signal to noise ratio (SNR) of 
the received US signal due to the low electromechanical coupling coefficient of the PVDF film, 
we implemented pulse compression technique using chirp signals. Comparisons among the 
different SNR values obtained with short pulse and after pulse compression with chirp signal 
show a clear improvement of the SNR for the compressed pulse. The axial resolution of the 
imaging system improved with increasing sweep bandwidth of input chirp signals, whereas the 
lateral resolution remained almost constant. This work demonstrates the feasibility of using a 
PVDF film transducer as an US transmitter and implementing pulse compression technique in an 
acoustic lens focusing based imaging system. 
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CHAPTER 1: Introduction & Overview of the Study 
1.1 Introduction: 
Photoacoustic (PA) imaging is a noninvasive soft tissue imaging modality which has found a 
rapid growth of interest in the last decade. Multiwavelength PA imaging has the potential to 
carry out functional imaging of tissue which may lead to early detection of cancer. The low 
intensity non-ionizing laser light used in PA imaging poses no health hazard, unlike the ionizing 
radiation associated with some of the common medical imaging modalities like X-ray computed 
tomography (CT), positron emission tomography (PET) and single photon emission computed 
tomography (SPECT). PA imaging depicts the optical absorption property of the tissue. Since the 
optical absorption property of a tissue changes with wavelength, using multiwavelength PA 
imaging or PA spectroscopy, it is possible to carry out functional imaging of important 
physiological parameters like concentration of different chromophores [light absorbing tissue 
constituents] or oxygen saturation of hemoglobin etc. of the tissue [1.1]. As the name suggests, 
PA imaging is a hybrid imaging modality where pulsed laser light exposes and penetrates the 
tissue and sound waves are emitted by the absorbers within the tissue. PA imaging keeps some of 
the specific advantages of both pure optical as well as pure ultrasound imaging. Like pure optical 
imaging, the PA image contrast depends on the optical properties of the tissue and thus the PA 
imaging can provide better contrast and tissue differentiation than Ultrasound (US) imaging 
where the contrast comes from the difference in mechanical properties inside the tissue. At the 
same time, like pure US imaging, it provides good spatial resolution at significant depth inside 
the tissue in contrast with pure optical imaging where resolution degrades significantly with 




tissue. With PA imaging, one can depict optical absorption properties of the tissue constituents 
up to a few centimeters (cm) deep with sub-millimeter (mm) resolution [1.1].  
Currently, the primary clinical imaging modalities used for diagnosis, management or treatment 
guidance of cancer are US, X-ray CT, magnetic resonance imaging (MRI), PET and SPECT. 
Although most of these technologies are well established and widely used in practice for cancer 
imaging and several other applications, there are problems related to low sensitivity and 
specificity for cancer detection and health hazards associated with them. As most of the 
modalities still lack specificity, consequently, when a suspect lesion is visualized, biopsy is 
required for confirmed diagnosis as well as prognosis. There are some other imaging modalities 
like contrast enhanced ultrasound imaging (CEUS), magnetic imaging spectroscopic imaging 
(MRSI) which are derivatives of these primary imaging modalities that may offer better 
detection ability than the primary modalities, but issues like cost, long treatment duration and 
operator dependency are associated with them.  
Because of all these reasons, there is always need for a new imaging modality which will detect 
cancer regions with high accuracy without posing any health hazard. PA imaging due to its 
optical property based contrast and better penetration potential than pure optical imaging 
modalities, is a suitable candidate to fill the requirement for a better cancer imaging modality. 
Also, the fact that PA and US share the same signal receiving technology, makes it possible to 
build a dual mode PA and US imaging system which can provide automatically co registered PA 
and US images. 
Several optical and physiological properties of a soft tissue specimen can be extracted from PA 




particular tissue pathologies. The optical absorption property at a certain location of the tissue 
actually depends on the concentration of the different types of chromophores present at that 
location and absorption properties of the individual chromophores. In the spectroscopic 
application of PA imaging, wavelength dependent optical absorption property of tissue, which 
can be used to compute concentration of different chromophores, can be recovered from PA 
images acquired at multiple wavelengths. For example, the malignant tumors are generally 
expected to be hypoxic (oxygen deficient), i.e. the concentration of deoxyhemoglobin is 
expected to be higher in the malignant regions than benign or normal tissue [1.1].  Different 
tissue abnormalities are rich in the content of one or more specific tissue constituents or 
chromophores, which to some extent become signatures of the particular tissue abnormalities. 
So, the concentration of different chromophores will provide specific physiological and 
molecular information about the particular tissue abnormality. For example, blood oxygen 
supply plays a very critical role in angeogenesis for malignant tumors. Important functional 
information about angiogenesis can be obtained from the knowledge of blood oxygen saturation 
which can be calculated using the concentrations of chromophores like deoxy hemoglobin and 
oxy hemoglobin [1.1]. Chromophore concentration and wavelength dependent PA image contrast 
or PA pixels depend on the amplitude/intensity of the locally generated PA signal via local 
optical absorption property. Frequency spectra of depth dependent one dimensional (1D) PA 
signals contain significant information about the structure of PA absorbers along the depth of the 
tissue specimen. By analyzing PA frequency spectrum, several metrics can be recovered which 
may potentially better characterize different tissue types. This study has focused on examining 
different features extracted from PA image data of tissue specimens and then testing the 




visualization of physiological or optical information in the form of intensity modulated 
parametric image of the object of interest using PA data and thereby detecting abnormalities 
present in the object. In this study, using statistical tools, the capabilities of different features in 
predicting different tissue pathologies were compared. To the best of our knowledge, this is the 
first ever large scale study in which frequency domain parameters have been extracted from ex 
vivo multiwavelength PA data generated by freshly excised tissue specimens from actual cancer 
patients [prostate: 30 patients, 53 region of interests, thyroid: 20 patients, 41 region of interests]. 
The common medical imaging modalities can be divided grossly into two categories i) imaging 
modalities that reveal the internal anatomical structure and ii) methods that present mapping of 
physiological function [1.4]. PA imaging tends to fall more in the second category than the first. 
But, in addition to detection of a particular tissue abnormality and some of its physiological 
information, it is also important to localize the abnormality for making a definite treatment plan. 
Although it performs poorly in detecting malignant tumors at early stage, US imaging can reveal 
major anatomical cues like boundary of major organs that can be used for identifying the 
location of tumor detected by PA imaging. Since the receiving technology is the same for both 
PA and US imaging, it is possible to make a dual mode imaging system which shares the same 
receiving set up and thus produces co-registered PA and US image of a tissue sample. A 
secondary focus area of this study was to develop and test a pulse echo US imaging system, 
compatible with our existing ex vivo PA imaging system. 
1.2 Overview of Study  
Preclinical studies with PA imaging is just beginning. Therefore there is not enough literature on 




many researchers have tried to extract features which reveal different information about tissue 
specimens, very few of them tried to build a multidimensional feature space with them and then 
use it to predict different tissue types. None of these researches, to the best of our knowledge, 
have tried to compare the performances of features belonging to different categories. In addition 
to that, as mentioned earlier, this is the first ever study with frequency domain parameters 
involving a large number of excised human tissue specimens. The results of this study shine 
some light on the potential of different features extracted from PA data so that in future it may be 
used as a guide to initiate a large scale clinical study with human patients for testing the potential 
of computer based diagnosis (CAD) with multiwavelength PA imaging. Although some thyroid 
specimens were also considered for this study, the primary attention was given to PA image 
analysis for prostate cancer detection. 
A dual mode imaging system capable of acquiring co-registered PA and US images of the same 
tissue specimen, will provide functional as well as structural information of tissue. The novel US 
imaging system, developed in this study, is compatible with our existing ex vivo PA imaging 
system. 
The major aims of this study were 
 Using marked histology slides as ground truths, identification of the region of interests 
(ROI) in the multiwavelength 3D PA dataset acquired on freshly excised prostate and 
thyroid specimens. The PA dataset were acquired prior to the commencement of this 
thesis work. 




 Statistical analysis of the extracted features to test whether they are significantly different 
between malignant, benign and normal tissue. 
 Building a multidimensional (29 dimensional) feature space with the extracted feature 
and identification of a suitable classifier for testing the ability of the feature space to 
predict malignant and nonmalignant prostate tissue. 
 With the same classifier previously identified, comparing the performances of the 
features belonging to different categories for predicting malignant and nonmalignant 
prostate tissue. 
 Design and characterize a novel pulse echo US imaging system compatible with our 
existing PA imaging system. 
Contribution of this study to the field of PA imaging for cancer detection is that it has 
identified and successfully filled up the following gaps present in the said field 
 A large scale study for tissue characterization using PA frequency domain parameters 
with PA data generated by tissue specimens of actual cancer specimens was unavailable. 
 To the best of our knowledge, no higher order data analysis study in which time domain 
and frequency domain PA features were combined and used in a CAD system for prostate 
cancer diagnosis, was available.  
 Performance of frequency domain PA parameters for tissue characterization was never 






1.3 Organization of the Thesis 
CHAPTER 2: PA Imaging and Prostate Cancer Imaging Modalities: This chapter covers a brief 
introduction of PA imaging and a review of imaging modalities which are clinically available as 
well as in the research stage for prostate cancer imaging. 
CHAPTER 3: Preliminary Works: This chapter covers the description of ex vivo PA imaging 
system, PA system characterization, experimental protocol for acquiring ex vivo PA images and 
ROI selection using ground truths. 
CHAPTER 4: Feature Extraction from Time Domain PA Signal: This chapter covers feature 
extraction from multiwavelength time domain PA data generated by the excised tissue 
specimens. It contains the results of statistical analysis, performed to test whether the features are 
significantly different among cancer, benign and normal tissue. 
CHAPTER 5: Feature Extraction from Frequency Domain PA Signal: This chapter covers 
feature extraction from frequency domain multiwavelength PA data generated by the excised 
tissue specimens and corresponding statistical analysis of the extracted features belonging to 
different tissue categories. It also contains modeling of time dependent 1D PA signals and the 
corresponding frequency spectra generated by PA absorbers of different shapes. 
CHAPTER 6: Computer Aided Diagnosis Using Extracted PA Features: This chapter covers the 
formation of a multidimensional feature space using the extracted features and the performances 
of different classifiers using the feature set to predict malignant and nonmalignant tissue. It also 
contains the comparison of performances of features belonging to different categories for 




CHAPTER 7: Novel US Imaging System: This chapter covers the development and 
characterization of the pulse echo US imaging compatible with our existing PA imaging system. 
CHAPTER 8: Discussions, Conclusions & Future work: This chapter covers the discussions, 
conclusions of this study along with the possible future works. 
APPENDICES: The Appendices contain some additional works performed and results obtained. 
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CHAPTER 2: PA Imaging and Prostate Cancer Imaging Modalities 
2.1 PA Imaging  
The generation of ultrasound waves by a light absorbing material following the absorption of the 
modulated light, usually pulsed laser light on a nanosecond timescale, is known as photoacoustic 
effect. The absorbed light energy produces localized heating which in turn produces a 
temperature rise, well below the amount of rise required to produce physical damage or phase 
change inside the object. This temperature increment gives rise to an initial pressure increase due 
to rapid thermal expansion. The pressure increase subsequently relaxes generating broadband 
low amplitude ultrasound waves. These ultrasound waves or better known as photoacoustic 
waves, emitted from the object, are captured by ultrasound transducers in different 
configurations depending upon the mode of imaging, to produce a sequence of A-line signals 
[2.1]. An A-line signal is simply the display of the time dependent response of the transducer 
generated by the ultrasound wave [2.2]. The A-line signals are suitably processed and combined 
to produce the 2D (two dimensional) photoacoustic images of the materials.  
The spectrum of the emitted acoustic waves can extend to several tens or even hundreds of 
Megahertz, depending upon the shape and structures of the light absorbers. Frequency dependent 
acoustic attenuation of the soft tissue limits the maximum frequency content of the emitted US 
wave. Due to frequency dependent attenuation, a tradeoff exists between the spatial resolution 
and the penetration depth. The higher the peak frequency of the emitted PA signal, the better will 
be the lateral as well as axial resolutions but the penetration depth will be poorer [2.3]. Some 
other factors, like detector bandwidth, detection configuration and detection area aperture limit 




than that of conventional pulse echo US images, as for pulse echo US imaging, localization can 
be achieved in both the transmit and the receiving beam whereas for the PA imaging, localization 
can be achieved only in the receiving beam and within 1 mm of the transmit beam. For pulse 
echo US imaging, the focal peak pressures of the US wave can be orders of magnitude higher 
than that of the US waves generated in case of PA imaging [2.1]. 
2.2 Prostate Cancer Imaging Modalities 
Prostate cancer is the second leading cause of cancer induced death in America, preceded by 
lung cancer. The American cancer society has estimated that, in the United States for the year 
2014, about 233,000 new cases of prostate cancer will be diagnosed with about 29,480 deaths 
[2.4]. From 2006 - 2010, the annual incidence of prostate cancer was 152 per 100,000 [2.5]. 
Typical prostate cancer screening procedures like digital rectal examinations (DRE) and 
prostate specific antigen (PSA) level checking have increased the percentage of early 
diagnosis (organ confined lower grade prostate cancer) of prostate cancer significantly [2.6, 
2.7]. There are certain challenges associated with early diagnosis of prostate cancer. Some 
of those challenges are related to selection of clinically relevant tumors among all types of 
detected tumors, treatment selection and long term consequences of specific treatment 
strategies [2.8, 2.9]. As the different medical imaging modalities are evolving rapidly, 
prostate cancer imaging is becoming increasingly important as it can assist in diagnosis, 
clinical assessment and treatment planning of prostate cancer. Following is a brief 
discussion about the roles of different conventional medical imaging modalities for 





2.2.1 Ultrasound Imaging:  
Persisting elevated Prostate Specific Antigen (PSA) levels and/or suspicious lesion felt on 
Digital Rectal Examination (DRE) leads to guided needle biopsy for prostate cancer diagnosis. 
Grayscale transrectal ultrasound (TRUS) imaging is the most widely used guidance tool 
associated with needle biopsy. Cancer regions are typically expected to appear hypoechoic 
in the US images although many prostate cancer regions appear isoechoic in TRUS images. 
The facts that almost half of the prostate cancer regions remain invisible in the US images 
and some of the commonly occurring benign prostate pathologies have similar appearances as 
cancer regions reduce the effectiveness of TRUS imaging as a diagnostic tool [2.10]. The 
sensitivity and specificity of TRUS in detecting prostate cancers is reported to be 41% and 81% 
respectively while the positive predictive value (PPV) and the negative predictive value (NPV) 
are found to be 52.7% and 72% respectively, with an accuracy of 67% [2.8]. Consequently 
TRUS guided needle biopsies generally are not targeted but systematic multi-core in nature that 
try to sample the entire gland using one of the many popular schemes [2.11]. Typically 5 to 12 
core samples are taken from various regions of the gland, but due to sampling errors, there is 
more than 20% chance of misleading the diagnosis [2.11, 2.12]. Although, TRUS imaging may 
not be very effective in detecting cancer lesions, it can be effectively used to measure the shape 
and volume of the prostate gland. Volume of the prostate gland can be used to measure PSA 
density [serum PSA level in nanograms/milliliter per unit volume of prostate in cubic 
centimeters] and grade of the cancer. TRUS has wide use in therapy also as it is used for guiding 
and directing the treatment in brachytherapy, cryotherapy and focal ablation of prostate tumors. 
Because of its wide availability and low cost, TRUS plays a major role in prostate cancer 




with prostate tumor growth, CEUS attempts to increase the sensitivity of cancer lesion detection 
by visualizing passage of injected gas encapsulating spheres or microbubbles in the bloodstream 
through the prostate. Harmonic imaging technology can be used alongwith CEUS imaging to 
potentially reduce the number of sampled cores in systematic biopsy [2.10]. Elastography, where 
rigidity and elastic property of prostate is measured and cancer lesions are identified using the 
measure of firmness, is another approach of ultrasound imaging for prostate cancer diagnosis 
[2.8].  
2.2.2 Magnetic Resonance Imaging 
MRI can also be used for prostate cancer detection. In T2-weighted MR imaging, cancer 
lesions are typically expected to generate low signal regions in the background of high 
signal regions corresponding to normal tissue, whereas in T1 images homogeneous signal 
intensity is generated throughout the prostate gland making detection of the cancer lesions 
impossible. Similarity in appearance of some of the benign prostate pathologies with 
prostate tumor in T2 weighted MR images lowers the specificity of MRI [2.8]. There are 
some suggestions of using MR imaging for prostate cancer screening, but that has not been 
implemented widely due to its high cost and low specificity [2.8]. The idea of using MRI for 
needle biopsy guidance is under consideration where the major obstacles are its high cost, 
procedural duration and limited reach, specifically towards the base of the prostate [2.8, 
2.13]. Endorectal MR imaging can be used efficiently for staging of prostate cancer 
although there are some concerns about inter-observer variability [2.9]. Spectroscopic MR 
imaging, which measures the concentrations of different metabolites in tissue and thus can 
differentiate a cancer region from its surrounding normal tissue by the difference of the 




Spectroscopic MRI can be potentially used to assess tumor aggression, measure recurrent 
cancers and combined use of MR with spectroscopic MRI can be used for guided needle 
biopsy [2.8]. Dynamic contrast enhanced MRI can potentially detect angiogenesis at cancer 
lesion and thereby increase the accuracy of prostate cancer detection [2.9]. Diffusion 
weighted imaging can be a potential tool to detect recurrent prostate cancer by measuring 
the diffusion coefficient of water in intracellular and extracellular spaces [2.8, 2.9]. Using 
lymphotrophic superparamagnetic nanoparticles as contrast agents, MR images can 
potentially detect metastasis [2.8]. Multiparametric MRI which combines more than one of 
the MR based techniques mentioned before, can potentially increase the accuracy for 
prostate cancer diagnosis and staging [12].  
2.2.3 X-ray Computed Tomography (X-ray CT) Imaging 
Computed tomography has very limited application in prostate cancer detection or staging at 
the primary level. It is generally used for staging of prostate cancer in the patients who have 
suspected metastatis [2.8]. 
2.2.4 Positron Emission Tomography  
The primary motivation of using positron emission tomography (PET) imaging to detect 
prostate cancer is that prostate cancer, because of its high metabolic rate and glucose 
consumption through glycotic pathway, will show higher uptake of glucose analog than 
normal prostate. Primarily, PET studies use fluorodeoxyglucose (FDG) as the radiolabelled 
analogue of glucose to detect cancer lesions by measuring the metabolic rate of tissue [2.8]. 
But various studies have shown disappointing results concerning the sensitivity of FDG PET 




between prostate cancer and benign prostatic hypertrophy [2.13]. Studies with other types of 
tracers like radiolabelled amino acids which will detect lesions with high protein  synthesis, 
are being pursued [2.8]. Combination of PET and CT has the capability of identifying the 
location of prostate tumor in prostate bed [2.9].  
Among the different imaging modalities discussed above, TRUS is expected to remain the 
primary imaging tool for screening and diagnosis of prostate cancer because of its wide 
availability, relatively low cost, easy to use nature as well as its role in guided needle biopsy 
[2.9, 2.14]. But due to its low sensitivity and specificity, there is considerable diagnostic 
uncertainty associated with TRUS. Even when it is used for guiding needle biopsy, due to 
its limited ability in detecting and localizing the cancer lesions, the complete gl and has to be 
sampled systematically. The sensitivity of the procedure increases with the number of 
sampling, but the procedure become very painful after a certain number of samples [2.9]. As 
US does not have any prognostic value, so patients at risk of having prostate cancer have to 
be under active surveillance and undergo repeat biopsies even after negative initial biopsy. 
As a result, patients have to undergo tremendous anxiety, physical discomfort and additional 
burden of cost. As mentioned earlier, there have been attempts to improve the accuracy of 
TRUS imaging by introducing several US based methods like CEUS, elastography etc., but 
they have not improved the accuracy significantly [2.16 – 2.19]. Among the other available 
imaging modalities, multiparameteric MR imaging seems to be the most suitable choice for 
achieving high diagnostic accuracy. But due to the high cost and long procedural duration, it 
cannot be performed on every patient at risk of prostate cancer. So, there is a need of a new 
imaging modality which will have high sensitivity as well as specificity for prostate cancer 




modality which can be integrated with TRUS seems to be an extremely suitable choice  not 
only for effective detection and localization of prostate cancer but also for proving guidance 
to optimized needle biopsy. 
2.3 Photoacoustic Imaging for Prostate Cancer 
 Yasseen et al. acquired in vivo PA and US images of a canine prostate containing induced 
blood rich lesion and observed that the induced lesion was visible in the PA image while US 
image did not show it [2.20]. In a similar study, Wang et al. acquired multiple in vivo PA 
and US images of pseudo lesion contained canine prostate and they observed the mean PA 
intensity of the pseudo lesion increased linearly with the volume of the total blood injected 
in the pseudo lesion [2.21]. Baur et al. performed coregistered 3D PA and US imaging and 
PA spectroscopy on mice, injected with PC-3 prostate tumor cells in a window chamber, to 
monitor tumor size and vasculature [2.22]. In a similar study, Olafsson et al. investigated 
tumor progression within mice in window chamber by performing contrast enhanced PA 
imaging with the use of gold nanorods [2.23]. Brachytherapy is an important option for 
prostate cancer treatment. It is a minimally invasive surgical procedure in which multiple 
seeds or grain sized radioactive sources are placed permanently inside the prostate so that 
their combined radiation is directed to destroy cancerous tissue [2.24]. For accurate 
positioning of the seeds at desired sites, real time guidance and position feedback by a 
suitable imaging modality is required. Although, TRUS is the common imaging modality 
used for these purposes, due to its poor imaging quality, the position feedback is not 
sufficiently accurate. As metallic brachytherapy seeds have high optical absorption 
coefficient compared to that of soft tissue, so PA imaging is expected to provide high 




can be very suitable for brachytherapy seed plant. Using a tissue phantom, Harrison and 
Zemp observed that at 1064 nm wavelength, PA imaging can detect brachytherapy seeds 
uniquely up to 5 cm deep inside the soft tissue with 26.5 dB contrast to noise ratio while the 
input laser fluence was maintained at ANSI limit for human exposure [2.25]. Su et al. 
acquired PA and US images of excised bovine tissue with seeds implanted in it and they 
found that PA images yield improved contrast ranging from 2.7 dB to 27.9 dB over US 
imaging for imaging depths ranging from 4 cm to 13 cm while the longer axis of the seeds 
was parallel to US transducer face [2.26]. Kuo et al. performed ex vivo PA imaging of 














CHAPTER 3: Characterization of the Pre Existing PA Imaging System and ROI Selection 
3.1 Ex vivo PA Imaging 
3.1.1 Literature Review 
Depending upon the detection configuration, primarily there are two different PA imaging 
modes, namely  
A. Photoacoustic tomography (PAT). 
B. Photoacoustic microscopy (PAM). 
Ideally, to form an image of a point absorber, the entire portion of the emitted PA wave 
generated by the object needs to be acquired by the US transducer. In PAT, this is accomplished 
by acquiring the PA wave either with a specially designed transducer array where the array 
elements are arranged along a particular geometry or with a single element transducer, 
mechanically scanning around a particular geometry depending upon the shape of the object 
while the complete object is irradiated by a large diameter diffused laser light. Then a suitable 
beamforming algorithm is employed to reconstruct the required two dimensional (2D) or three 
dimensional (3D) PA images from the acquired PA signals [3.1 – 3.4]. In PAM, either a focused 
transducer is mechanically scanned to collect the emitted PA wave or a tightly focused laser 
beam is used to scan the object where the transducer remains stationary. The required PA images 
are formed directly from the set of PA signals without using any kind of beamforming 
algorithms [3.5 – 3.11]. PAM can be further divided into two categories depending upon the PA 
image acquisition setup. If the focused transducer is used to scan the object i.e. if the point 




mode is known as Acoustic resolution photoacoustic microscopy (AR-PAM) [3.6 – 3.9]. If the 
focused laser beam is used to scan the object i.e. if the lateral resolution is determined by the 
diffraction limited tightly focused laser beam width, then the corresponding imaging mode is 
known as Optical resolution photoacoustic microscopy (OR-PAM) [3.10 – 3.11]. The primary 
advantage of using a focused transducer as used in the conventional PAM mode, is that no 
beamforming algorithm or electronic focusing is required and consequently there are no errors in 
the reconstructed image due to spatial and temporal sampling of the signal.  However one 
disadvantage with a focused transducer is that at one point of time, only one point in the tissue 
sample will be in focus since the focusing element is typically placed on top of the single 
element transducer and thus a significant amount of time will be required to scan an object of 
significant dimension.  
3.1.2 Development of the Ex vivo PA Imaging System [Prior Work] 
Prior to the commencement of the present study, the ex vivo PA imaging acquisition system was 
developed in our laboratory. Although it was not a part of the present study, for the sake of 
understanding and completeness, the PA imaging system has been described in a concise way. 
An acoustic lens based setup has been employed in our ex vivo PA imaging setup. Here, the 
focusing element i.e. the acoustic lens is separately placed from the transducer and thus at a 
certain time instant instead of a single point, a whole plane is in focus. The acoustic lens is 
actually placed in between the tissue and the transducer and creates a focused image of the 
object/tissue on the image plane i.e. on the transducer. Thus, in principle, this set up can acquire 
the focused image of the object plane/tissue surface almost instantaneously with a 2D array, just 
like a conventional optical camera. The object plane here corresponds to the coronal plane in the 




plane to their corresponding conjugate points on the image plane is usually less than the 
difference of time between two consecutive zero crossing points in the time dependent PA 
signal. Therefore the entire image plane is in focus and is conjugate to the corresponding object 
plane [3.12].  
Figure 3.1 shows the ex vivo PA imaging system developed in our laboratory.  
 
Figure 3.1: Ex-vivo PA imaging system (A) Acoustic lens focusing based PA image acquisition 
approach (B) The actual PA imaging probe with tissue sample holder. 
Transillumination geometry, in which the light source and US transducer are placed on the 
opposite sides of the tissue specimen, was employed in this PA imaging system. Figure 3.1A 
shows the concept behind the acoustic lens based focusing approach. Once the prostate specimen 
was illuminated with pulse laser beam, the light absorbing tissue constituents absorbed laser light 
and emitted PA waves which travelled to all directions. The portions of the PA waves travelling 
towards the cylinder containing the acoustic lens and transducer array, were focused by the 
acoustic lens on the transducer array. To achieve unit magnification, the object distance i.e. the 




between the acoustic lens and the transducer array were made equal to twice the focal length of 
the acoustic lens. Figure 3.1B shows the actual ex vivo PA imaging setup developed in our 
laboratory. The adjustable laser arm holds the fiber bundle which delivers the pulsed laser light 
from the tunable laser (wavelength: 700 - 1000 nm, pulse repetition frequency: 10 Hz, pulse 
duration: 5ns (nanosecond), EKSPLA, Vilnius, Lithuania) on the tissue sample holder. The 
sample holder can accommodate tissue samples up to 4 cm thick. During PA imaging, the 
sample holder and the water sealed cylinder containing the custom designed acoustic lens (focal 
length: 39.8 mm, diameter 32 mm) and the 32 element 1D US transducer array (OLYMPUS 
NDT, State College, PA,USA) were both filled with saline water. Center frequency and pitch of 
the transducer array are 5 MHz and 0.7 mm. The fiber bundle carrying arm and the cylindrical 
container are attached with each other and together they will be referred as PA camera from now 
on. The depth of field of the lens is approximately +/- 0.5 cm around the focal plane. Figure 3.1A 
shows that if we receive the signal at each of the 32 elements of the 1D transducer array over a 
sufficiently long time gate and then map the corresponding arrival times to distances, then we 
will get 32 adjacent 1D radio frequency (RF) PA signals or A-line PA signals, which can be 
further processed to produce a focused B-scan image representing a particular sagittal plane.  To 
acquire PA image of an excised tissue specimen, the specimen was held stationary by the sample 
holder and using dual axis linear stepper motors, the PA camera raster scanned the specimen to 
acquire a set of PA A-line signals over a long time gate. A C-scan image i.e. image representing 
particular transverse planes is formed by applying a narrow time gate to the whole set of the A-
line PA signals. The transducer array is connected to a custom designed data acquisition (DAQ) 




in the computer. We use our own Matlab (v2012a, Mathworks Inc., Natick, MA, USA) based 
software to form different C-scan or B-scan images from the stored PA dataset.   
3.1.3 Multiwavelength PA Imaging of Excised Human Tissue Specimens [Prior work] 
Photoacoustic imaging at five different wavelengths was performed on the freshly excised 
human prostate and thyroid specimens. Imaging as well as data collection was done prior to the 
present study. For the sake of completeness, the experimental protocol is described here. The 
prostate specimens were collected from patients who underwent prostatectomy for biopsy 
confirmed prostate cancer. The excised thyroid specimens were collected from patients with 
suspected thyroid lesions after they underwent thyroidectomy. Before proceeding with the 
studies, approval from Institutional Review Board (IRB) was obtained along with consent from 
each patient. The studies were in compliance with Health Insurance Portability and 
Accountability Act.  
Experimental Protocol for ex vivo imaging of excised tissue specimens: 
 




Figure 3.2 shows the experimental protocol, used for acquiring multiwavelength PA images of 
excised human tissue specimens. Immediately after surgery, the excised prostate or thyroid 
specimen was sent to the surgical pathology laboratory where it was inked and cut into thin 
sections (2-5 mm thick) by a pathologist. One such section with a grossly visible nodule was 
selected, immersed in normal saline to prevent dryness and sent to our laboratory where we 
acquired PA images of it at five different wavelengths. Once PA imaging was done, the tissue 
specimen was returned to the surgical pathology laboratory for histopathology. The complete 
process of sectioning the excised specimen, acquiring the PA images and then returning it to the 
surgical pathology laboratory was finished within 1 hour after surgery. It was verified and 
approved by the pathologist to ensure that the histopathology procedure of the specimen was not 
compromised. The laser intensity on the excised prostate specimen was maintained around 5 mJ 
(milli Joules)/cm
2
 which is well below the safe human exposure limit according to American 
National Standards Institute guidelines [3.13]. 
Choice of wavelengths: 
The five wavelengths, at which the PA images were acquired, were chosen in such a way that 
each wavelength corresponds to the peak of the absorption spectrum of a particular chromophore 
in the 700 nm – 1000 nm wavelength range. Chromophores are the light absorbing tissue 
constituents. Following are the pairs of selected wavelength and chromophore with peak 
absorption at the selected wavelength: 760 nm – deoxyhemoglobin (dHb), 850 nm – 
oxyhemoglobin (HbO2), 930 nm – lipid and 970 nm – water [3.14 - 3.16]. The additional 
wavelength 800 nm was chosen as at this wavelength, absorption coefficient of both dHb and 




3.2 PA Image Formation and ROI Selection  
3.2.1 PA Image Formation 
The entire cross sectional surface of the tissue sample is raster scanned by the PA camera to 
acquire a set of A-line PA signals, each element of the transducer array generating one A-line 
signal. An A-line signal contains the time dependent one dimensional (1D) RF PA signals 
plotted against time/ Z axis. Since the acoustic wave has finite velocity, the arrival times of the 
A-line signal can be mapped to the depth of the absorbers along Z axis. The instant when the 
laser starts firing the pulses, is time t = 0. The PA signals acquired by all the 32 channels of the 
transducer array at each position of PA camera are transmitted simultaneously to the custom 
made DAQ unit which contains a variable gain amplifier and digitizer to suitably amplify and 
digitize/sample the acquired data. A grayscale plot of the adjacent envelope detected A-line PA 
signals in the XZ plane produces the 2D B-mode [Brightness - mode] image. The entire set of A-
line signals forms 3D PA signal, generated by the tissue sample. A constant depth C-mode image 
or cross-sectional image is produced by applying a small time gate to the entire set of envelope 
detected PA A-line signals and creating brightness modulated display by taking the mean of the 






Figure 3.3: (A) A typical excised human prostate tissue specimen (b) C-mode PA image of the 
prostate tissue sample, taken at 760 nm wavelength. 
Figure 3.3A shows a photograph of the prostate tissue sample taken with a conventional camera 
as the sample was held in the sample holder and ready to get raster-scanned for obtaining the PA 





Figure 3.4: (A) prostate tissue sample (B) A-line PA signal corresponding to highlighted grid 
point or pixel in red in the prostate sample, the blue line represents the RF signal while the red 
line represents the envelope detected RF signal (c) PA B-mode image corresponding to the array 
of pixels marked by the red rectangle in the image of the prostate sample.  
Figure 3.4 shows the raster scan geometry of the prostate tissue sample. It also shows how the 
PA A-line signals and B-mode PA images are generated. The object plane/tissue surface can be 
imagined as a grid of square elements due to the finite size of the transducer elements. Tissue 
under each square element generates an A-line PA signal and envelope detected brightness 
modulated plot of the adjacent A-line signals of each column of the grid in the XZ plane 







Figure 3.5: C-mode image formation (A) PA A-line signal corresponding to a particular point on 
the tissue sample, (B) B-mode PA image in the XZ plane, (C) C-mode PA image in the XY plane 
generated by applying the small time gate, shown by the dashed black rectangle in 3.5A applied 
to the complete set of envelope detected A-line signals. 
Figure 3.5 shows how the 2D C-mode images representing different cross sectional planes have 
been generated by time-gating the A-line signals. Each A-line signal has been sampled with a 
sampling frequency 30 MHz, as the maximum detected frequency cannot go over 15MHz. The 
A-line signals have been studied carefully. The length of each A-line signal is around 133μs, the 
first 100μs length of each A-line signal have been ignored as those data come from the 
cylindrical container of the PA camera. Out of the rest i.e. 33μs long data, only around 2μs to 4μs 
long data were generated by 3mm to 5mm thick tissue samples. The portion of the A-line signals 
generated by the tissue samples is identified closely inspecting the PA A-line signals. As 
mentioned earlier, for generating a C-mode image from the 3D dataset a small but suitable time-
gate is required. The center of the time gate is chosen as one of the peaks of the tissue generated 
portion of a significant A-line signal. The width of the time gate is generally short, around 0.2μs, 






C-mode images formed by applying separate time gates to the tissue generated PA A-line 
signals. The C-mode PA image is generated by creating a brightness modulated display with the 
mean of the envelope detected time gated portions of the PA A-line signals along Z axis and. 
3.2.2 ROI selection 
Using marked histology images as ground truth, ROI corresponding to cancer, normal and 
benign tissue were selected in this study. The histopathologist performed histopathology on each 
excised specimen, imaged in our laboratory.  The digital images of the marked histology slides 
were co registered with the C-scan PA images of the specimens to identify the ROIs 
corresponding to different tissue pathologies. Generally the PA images do not show any 
prominent features/cues which can help to register the PA images with the digital histology 
slides. As mentioned previously, before slicing the original excised tissue specimen into thin 
sections, the pathologist inked it. This ink generated pretty high PA signal at all the five 
wavelengths. The high signal generated by the ink defined the boundary of the specimen in its 
PA image and that boundary guided us in registering the PA images with the histopathology 
images. The registration between the 2D C-scan PA images with the digital histology images 
were achieved manually. We tried boundary extraction and projective geometry based automatic 
registration, but that was not very successful for all of the specimens. The form and depth of high 
intensity boundary produced by the ink signal were not consistent for all the specimens. Many 
large specimens were divided into smaller sections before histology which required stitching of 
histology images of tissue portions before registration. Because of these reasons and the huge 
difference in resolution between the PA images [64 x 45] with the digital histology images [512 
x 1024], the automatic registration was not successful. The manual registration was a two step 




tissue specimen, captured in our laboratory before acquiring PA images. In the next step, the 
digital image of the tissue specimen was registered with the C-scan 2D PA image. Thus ROIs in 
the PA images corresponding to the marked regions in the digital histology images can be 
identified.  
 
Figure 3.6: Digital image of a thyroid tissue specimen containing malignant region (B) Marked 
digital histology image, malignant region marked by the blue circle (C) Corresponding C mode 
PA image, a ROI in the center of the malignant region is marked by the white circle. 
Figure 3.6A shows the digital image of a particular thyroid tissue specimen and Figure 3.6B and 
3.6C show the corresponding marked digital histology image and the C-scan PA image. The 
malignant region is marked by the blue circle in 3.6B while a ROI corresponding to the 
malignant region is marked by the white circle in Figure 3.6C. To make the process of manual 
registration accurate, we built a graphical user interface (GUI) tool using matlab. The digital 
images of the tissue specimens were captured placing two small scales on top and left of the 
specimen. Using these scales and the GUI, we measured the dimensions of the tissue specimen. 




the dimensions and position of the ROI, relative to the boundary of the histology section. Next 
we identified the boundary produced by the high intensity ink signal in the C-scan PA image and 
selected a ROI using the dimension and relative position information retrieved from the 
histology image.  
 
Figure 3.7: Matlab based GUI for ROI selection the PA images. The three images in Figure 
3.6A, 3.6B and 3.6C are shown in the three panes. 
Once a ROI was identified in a C-scan image the same ROI was applied to the 3D PA dataset to 
select the PA A-line signals corresponding to particular tissue pathology.  
3.3 Characterization of the Ex vivo PA Imaging System 
Detail characterization of the ex vivo PA imaging system was a part of this study. For 
characterizing the system, we measured 2D point spread function (PSF) of the system in the XZ 
plane, sensitivity of the system at different depths inside soft tissue and variation of 2D PSF with 




3.3.1 Point spread function in X-Z plane [B-scan image plane]: 
PSF of our ex vivo imaging system in the XZ plane was measured using a 0.2 mm diameter lead 
pencil as the target in a water bath. The lead pencil was placed perpendicular to the axis of the 
transducer array of the PA imaging probe so that it behaved like a point source in the XZ plane. 
 
Figure 3.8: Experimental setup for measuring PSF in the XZ plane. 
Figure 3.8 shows the experimental setup for measuring the PSF of our ex vivo PA imaging 
probe. Here the lead pencil was placed in a water bath and the laser light illuminated the lead 
pencil from side without any fiber bundle. The probe was placed directly on top of the lead 
pencil in such a way that the pencil remained at right angle to the X axis or azimuth of the 
transducer array and the center of the probe saw the pencil. The distance between the face of the 
probe and the lead pencil was kept very small [~ 5 mm], so that the pencil could maintain an 
object distance approximately equal to the twice the focal length of the acoustic lens from the 




acoustic lens on the transducer array. To acquire PA data, 800 nm wavelength of the tunable 
laser was used. 
Results: 
 
Figure 3.9 (A) 2D PSF of the ex vivo PA imaging probe in XZ plane (B) Lateral cut (along 
azimuthal/X axis) of the 2D PSF in A (C) Axial cut (along time/Z axis) of the 2D PSF in A. The 
pair of red lines in Figure 3.9B and 3.9C show the Full width half maximum (FWHM) along the 
lateral and axial direction. The lateral FWHM is 2.45 mm while the axial FWHM is 0.34 mm. 
Figure 3.9 shows the 2D PSF of the ex vivo PA imaging probe in XZ plane. FWHM of the 2D 





Figure 3.10: PA A-line signal and B-scan image with transducer array position (A) PA A-line 
signal acquired by the central element of the 32 element transducer array (B) B-scan PA image 
formed by envelope detecting the A-lines acquired by transducer array. 
Figure 3.10 shows the PA A-line signal and B-scan PA image generated by the lead pencil. 
3.3.2 Variation of 2D PSF with distance from PA Probe 
As mentioned in Section 3.3.1, during the measurement of 2D PSF of the PA imaging system, 
the distance between the PA probe and the target (lead pencil) was maintained around 5 mm so 
that the object distance for the acoustic lens was maintained approximately equal to twice the 
focal length of the lens. Maintaining the same setup as shown in Figure 3.8, we also measured 




between the PA probe and the lead pencil was changed with the help of a linear stepper motor 
within a range of 3 mm to 50 mm. 
 
Figure 3.11: PSF variation with distance between the target and PA probe (A) Variation of lateral 
FWHM with probe distance from target (B) Variation of axial FWHM with probe distance from 
target. 
Figure 3.11 shows the variation of FWHM along lateral as well as axial direction with the probe 
distance from target. From Figure 3.11A, it can be seen that the lateral FWHM seemed to change 
slightly with distance while Figure 3.11B shows that the axial FWHM remained uniform at all 
probe distances. 
3.3.3 Sensitivity measurement: 
To measure the sensitivity of the our experimental setup at varying depths inside soft tissue, we 
acquired PA images of chicken tissue with 0.7 mm diameter lead pencil inserted in it and 





Figure 3.12: Experimental setup for measuring sensitivity at different depths inside the chicken 
tissue. 
Figure 3.12 shows the experimental setup for measuring sensitivity at different depths inside 
chicken breast tissue. The chicken breast slab with a lead pencil inserted in it was placed in such 
a way that the pencil was at right angle to the azimuth of the transducer array and the center of 
the probe saw the lead pencil. The laser illuminated the chicken tissue with the lead pencil from 
side. The chicken tissue with lead pencil was placed in a water bath. We inserted the same lead 
pencil at different positions of the chicken breast slab such that the laser light had to travel 
different distances inside the tissue before it reached the lead pencil. Once inside the tissue, light 
is expected to be attenuated significantly due to absorption and significant scattering, caused by 
the tissue. The aim of the experiment was to determine, how deep our experimental setup could 




input laser intensity was around 30 mJ/cm
2
. For this experiment, the depth signifies various 
positions along X axis inside the tissue. 
Results: 
 
Figure 3.13: PA images of the lead pencil inserted at 0.5 cm depth (A) B-scan PA image (B) A-
line PA signal acquired by the center element of the transducer. 
Figure 3.13 shows the B-scan and A-line PA images of the lead pencil inserted at 0.5 deep inside 





Figure 3.14: PA images of the lead pencil inserted at 2 cm depth (A) B-scan PA image (B) A-
line PA signal acquired by the center element of the transducer. 
Figure 3.14 shows the B-scan and A-line PA images of the lead pencil inserted at 2cm deep 
inside the chicken tissue. The signal to background ratio, computed using Figure 3.14 is 2.6. 
 




Figure 3.15 shows a plot of signal to background ratio or sensitivity at different depths inside the 
chicken tissue. We can see that the sensitivity is reduced significantly at 2 cm depth. Beyond 2 
cm, we could not record any legible signal. As the input laser intensity for this experiment was 
on higher side, so for tissue imaging we can conclude that our experimental setup will be able to 

















CHAPTER 4: Feature Extraction from Time Domain PA Signal 
The aim of PA imaging is to gain important information related to physiology and composition 
of soft tissue and on the basis of those information, detect particular tissue abnormalities. In this 
study, we extracted different types of features from the ex-vivo PA images of human prostate 
and thyroid specimens. Using marked histology images as ground truth, region of interests (ROI) 
corresponding to malignant, benign and normal tissue were identified in the PA data and then the 
features were extracted from the selected ROIs. Statistical analysis with the extracted features 
was performed to test whether they were significantly different between different tissue 
pathologies. We used time domain PA signals as well as frequency spectrum of the RF PA 
signals to extract different features. The time domain features were extracted from C scan 2D PA 
grayscale images which were formed using mean of the envelope detected PA signal amplitudes 
acquired over a small time gate. The time domain PA features belong to two primary categories 
A. Multiwavelength PA pixels. 
B. Chromophore concentrations. 
Before going into details of the extracted time domain PA features, it is important to understand 
how the PA signal amplitudes depend on the optical properties of the soft tissue. 
4.1 Optical Properties of Soft Tissue  
 The interaction of light with the turbid tissue media can be classified in general into two 
categories, namely scattering and absorption. When the medium only redistributes the incoming 
light along different directions without altering it otherwise, then scattering takes place. But if 




of the medium, then the atom absorbs the photon, goes up to the higher energy level and then 
releases the excitation energy in the form of thermal energy. So in this process the incoming light 
energy is lost to some other form of energy. This is known as absorption. For a purely absorbing 
homogeneous medium [in absence of scattering or very low scattering], the absorption process is 
governed by the Lambert-Beer‘s law given by Equation 4.1[4.1] 
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Here, Iz is the light intensity at depth z, I0 is the input light intensity and μa is the optical 
absorption coefficient of the medium. Now, if the medium possesses scattering properties, then 
under the condition of μa > μs the Lambert-Beer law will be modified as Equation 4.2 [4.2] 
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Here μt and μs are the total attenuation coefficient and the optical scattering coefficient of the 
medium.  
For biological tissues, in the Near Infra Red (NIR) wavelength region, huge scattering of light 
takes place during the propagation of light through the medium. In fact scattering is the main 
source of attenuation of light inside the tissue. So, after a certain depth z, when z >> 1/μt, 
diffusion approximation can be applied to the radiative transfer Equation describing the 
distribution of light in the tissue. Diffusion approximation is applicable under the condition of μs 
>> μa. Under the diffusion approximation, the effective attenuation coefficient of the medium μeff 
will be given by 
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Here, μs
/
 is the reduced scattering coefficient of the medium and g is known as anisotropy 
parameter. The scattering phase function of the medium p(s, s
/




photon for scattering in s
/
 direction while before scattering it was travelling in s direction. If the 
scattering is axially symmetric relative to the propagation direction before scattering, then for a 
random scattering medium the scattering phase function will only depend on the angle between 
the direction of propagation before scattering s and scattering direction s
/
. In this case, the 
anisotropy factor will be given by Equation 4.4 
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Here θ is the angle between s and s
/
. The value of g will be in the range of -1 to +1. When g > 0, 
that means the scattering predominantly takes place in the forward direction whereas g < 0 
means dominant backward scattering and g = 0 corresponds to isotropic Rayleigh scattering [4.2 
– 4.3]. 
So, in case of biological tissue, the light fluence of a collimated incident beam will be 
determined by the diffused photons or μeff as in Equation 4.3 for the region z >> 1/μt and for the 
region corresponding to a smaller depth the light fluence will be determined by the μt as in 
Equation 4.2 [4.4]. The light fluence Φ, which can be expressed by Equation 4.5, is the integral 
of light radiance over all the possible directions. 
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Where υ (x, s) is the light radiance. The unit of fluence is watt/cm
2
. 
4.2: Multiwavelength PA Pixel  
The tissue and its major constituents (water, oxyhemoglobin and deoxyhemoglobin in blood, 
lipid, fat, melanin, collagen, etc) have widely varying absorption spectra [4.5] in the NIR region 
that not only provide abundant contrast features, but also open the door for PA imaging based 




different PA images of the same tissue sample are taken using different wavelengths of a tunable 
laser. The initial acoustic pressure p, generated following the absorption of the optical energy at 
time t=0 can be expressed by Equation 4.6 [4.4] 
                                   0
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Here, h is the spatial distribution of the absorbed energy density by the object/tissue and Γ is a 
tissue property known as the Grueneissen parameter. The parameters β and Cp represent isobaric 
volume expansion coefficient and heat capacity per unit mass of the spherical PA absorber, while 
c and E0 represent the velocity of PA wave inside the absorber and input laser fluence received 
by the absorber. Γ is basically the conversion factor between the absorbed optical energy density 
and the generated acoustic pressure. From Equation 4.6, it is clear that the acoustic pressure 
depends on the distribution of absorption coefficient throughout the tissue and so the C scan PA 








Figure 4.1: Multiwavelength PA imaging 
As shown in Figure 4.1, a tissue sample [represented by the light green cartoon], which contains 
different light absorbing tissue constituents or chromophores [represented by different colored 
circles inside the tissue] with different optical absorption properties, are irradiated with different 
wavelengths and as a results, PA images with different contrasts of the same tissue sample are 
acquired. Generally, the wavelengths are chosen in such a manner, that each wavelength 
corresponds to the peak of the absorption spectrum of a particular chromophore. The 
spectroscopic application of PA imaging aims for quantitative determination of the concentration 
of specific chromophores present in the tissue which can be further used for functional imaging 






4.2.1 Literature Review 
Laufer et al. [4.8] determined the blood oxygen saturation in a cuvette from the PA spectra taken 
at multiple wavelengths in the range of 740 nm to 1040 nm. Allen et al. [4.9] performed 
spectroscopic PA imaging of human arterial tissue ex vivo to demonstrate the feasibility of 
detecting the presence of lipid in human aorta.  Zhang et al. [4.10] measured dynamic blood 
oxygen saturation variation under different physiological states from PA microscopy data 
acquired in vivo from Sprague Dawley rats. As malignant tumor growth is generally associated 
with the formation of additional vasculature for providing necessary nutrients required for the 
growth [4.7], so the malignant tumors are generally richer in blood than benign or normal tissue. 
In the NIR region, the absorption coefficient of blood is orders of magnitude higher than that of 
the normal tissue [4.11]. So the stronger optical absorption in the NIR wavelength range by the 
blood rich malignant tumors will generate PA signals with higher amplitude than the amplitude 
of the background PA signal generated by the normal tissue. Generally, the malignant tumors are 
expected to be hypoxic (oxygen deficient), i.e. the concentration of deoxyhemoglobin is 
expected to be higher in the malignant regions than benign or normal tissue [4.7]. So if two PA 
images of a tissue specimen containing cancer are acquired at two specific wavelengths 
corresponding to the absorption spectra peaks of deoxyhemoglobin and oxy hemoglobin, then 
there will be significant difference in contrast between these two images for the cancer region. 
Using two wavelength PA imaging, while the wavelengths were tuned to absorption spectra 
peaks of deoxyhemoglobin and oxyhemoglobin, Oraevsky et al. acquired in vivo PA images of 






4.2.2 Prostate Specimen Results 
Using marked histology slides as ground truth, the ROIs corresponding to malignant, benign and 
normal tissue were identified in the 2D C-scan PA images. Pixels corresponding to the ROIs 
from C-scan PA images taken at five different wavelengths were extracted and analyzed. 
 
Figure 4.2: C-scan PA images of a freshly excised human prostate tissue sample taken at five 
different wavelengths; (A) Prostate tissue sample (B) Histology slide of the prostate tissue 
sample (C) PA image at 760 nm (D) PA image at 800 nm (E) PA image at 850 nm (F) PA image 
at 930 nm (G) PA image at 970 nm. ROIs corresponding to the cancer tissue have been marked 
by the blue circles whereas the adjacent normal ROIs have been marked by the white circles in 




Figure 4.2A shows the photograph of a typical prostate specimen before the PA imaging was 
done. Figure 4.2B shows the scanned histology slide of the prostate specimen shown in Figure 
4.2A. Five C-scan PA images, formed using the PA data acquired at five different wavelengths 
are shown in Figure 4.2C – 4.2G. In Figure 4.2B – 4.2G, the ROIs corresponding to malignant 
prostate are shown using blue circles while the adjacent normal prostate regions are shown by 
white circles. 
30 Patients were involved in the study for ex vivo PA imaging with excised prostate specimens. 
Data from a total of 53 ROIs were analyzed. According to the histopathology analysis performed 
by the genitourinary (GU) histopathologist, among the 53 ROIs, 19 ROIs were malignant, 8 
ROIs were Benign Prostate Hyperplasia (BPH) and the rest were normal.                                                                                                                     
Two sample two tailed t-test was performed with the pixel values extracted from the ROIs in the 
2D C-scan images to find out whether there was statistically significant difference between the 
PA pixels corresponding to ROIs of different tissue types. Figure 4.3 shows the results of the t-
test performed at 5 % significant level with the values of the PA pixels corresponding to 
malignant vs. normal, malignant vs. BPH, BPH vs. normal and malignant vs. nonmalignant. The 






Figure 4.3: Comparison of PA pixel values between different prostate tissue types (A) malignant 
vs. normal (B) malignant vs. BPH (C) BPH vs. normal (D) malignant vs. nonmalignant using 
two sample two tailed t-test. The dashed lines show the levels corresponding to decision criterion 
(p = 0.05). 
From Figure 4.3, it can be seen that between malignant and normal prostate tissue, the PA pixel 
values are significantly different (p<0.05) at all the wavelengths except at 930 nm. Between 
malignant and BPH prostate, besides 800 nm wavelength, PA pixel values are significantly 
different (p<0.05) at the other wavelengths. For BPH vs. normal prostate, PA pixel values at all 
of five wavelengths are significantly different (p<0.05) while between malignant and 
nonmalignant prostate, PA pixel value only at 930 nm is not significantly different (p>0.05).  
Two way analysis of variance (ANOVA) test was performed with the PA pixel values 




separate groups of tissue namely cancer, benign and normal, while wavelength contains five 
different wavelengths used for PA imaging. 









F p value 
Tissue category 3.70815e+07 2 18540761 83.76 2.30367e-36 
Wavelength 1.05258e+08 4 26314419.7 118.87 5.51165e-96 
Tissue 
category*wavelength 
5.02459e+07 8 6280742.6 28.37 2.40211e-43 
Error 8.89886e+08 4020 221364.7   
Total 1.10467e+09 4034    
 
Results of the two way ANOVA test shows that means of PA pixel values are significantly 
different between different tissue groups as the corresponding p value is very small [2e-36] and 
PA pixel value means are also different between different wavelength groups [p value = 5e-96]. 
As the p value corresponding to interaction term is very small [2e-43], the effects of wavelength 






4.2.3 Thyroid Specimen Results: 
Data from a total of 41 ROIs [collected from 20 patients] were analyzed. According to the 
histopathology analysis performed by the histopathologist, among the 41 ROIs, 9 ROIs were 
malignant, 18 ROIs were benign and the rest of the ROIs were normal.        
Figure 4.4 shows PA images of a particular thyroid sample taken at five different wavelengths. 
The thyroid specimen is shown in Figure 4.4A while the corresponding histopathology slide is 
shown in the Figure 4.4B. The marked areas in 4.4B are the nodules marked by the 
histopathologist. Figure 4.4C shows the histopathology slide overlaid on the thyroid specimen to 
identify the nodules in the thyroid specimen. Figure 4.4C has been co-registered with the C-scan 
PA images, shown in Figure 4.4D – 4.4H to identify the ROI. The ROIs corresponding to the 





Figure 4.4: Photoacoustic images of a freshly excised thyroid tissue sample taken at five 
different wavelengths; (A) Excised thyroid tissue sample (B) Digital image of the 
Histopathology slide of the thyroid tissue sample (C) Histopathology slide overlaid on the 
thyroid tissue sample (D) PA image acquired at 760 nm (E) PA image acquired at 800 nm (F) PA 
image acquired at 850 nm (G) PA image acquired at 930 nm (H) PA image acquired at 970 nm. 
ROIs corresponding to the malignant tissue have been marked by the blue circles in A, D, E, F, 
G, H. 
Two sample two tailed t-test was performed with the pixel values extracted from the ROIs in the 
2D C-scan images to find out whether there was statistically significant difference between the 




performed at 5 % significant level with the values of the PA pixels corresponding to malignant 
vs. normal, malignant vs. benign, benign vs. normal and malignant vs. nonmalignant thyroid 
tissue. The ROIs corresponding to benign and normal prostate tissue are grouped into the 
‗nonmalignant‘ category. 
 
Figure 4.5: Comparison of PA pixel values between different thyroid tissue types (A) malignant 
vs. normal (B) malignant vs. benign (C) benign vs. normal (D) malignant vs. nonmalignant using 
two sample two tailed t-test. The dashed lines show the levels corresponding to decision criterion 
(p = 0.05). 
From Figure 4.5, it can be seen that between malignant and normal thyroid tissue, the PA pixel 
values are significantly different (p<0.05) at all the wavelengths. Between malignant and benign 
thyroid also, PA pixel values are significantly different (p<0.05) at the wavelengths. For benign 




except for 970 nm while between malignant and nonmalignant prostate, PA pixel values at all the 
five wavelengths are significantly different (p<0.05) . 
4.3 Chromophore Concentration 
As mentioned earlier, the contrast in the PA images is determined by the optical absorption 
coefficient of the tissue. The optical absorption at a particular location of the tissue is the sum 
total of the optical absorption by the light absorbing tissue constituents or chromophores present 
at that particular tissue location. Although there may be various kinds of chromophores present 
in a particular tissue sample, for some wavelength ranges, only a few chromophores dominate 
the optical absorption. For example, in the NIR wavelength region, primarily deoxyhemoglobin 
and oxyhemoglobin dominate the optical absorption while lipid and water provide minor 
contributions towards the higher end of the NIR region. Spatially varying absorption coefficient 
of a tissue sample at different wavelengths can be recovered from the multiwavelength PA 
images of the tissue sample. The relation between the absorption coefficient μa(x, y) at a 
particular wavelength and the concentration of different chromophores can be written in the form 
of Equation 4.7 
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Here ck(x, y) is the concentration of the kth chromophore, αk is the specific absorption coefficient 
of the kth chromophore at the particular wavelength λ and N is the number of different types of 
chromophore present in the tissue sample [4.12]. Inverting Equation 4.7, concentrations of 
different chromophores (endogenous chromophores like oxy hemoglobin, deoxyhemoglobin and 
for some cases exogenous contrast agents) can be found out from the recovered absorption 




4.3.1 Literature Review 
Chromophore concentration from 1D PA imaging: The simplest form of the PA imaging is 1D 
PA imaging. This can be used to find out the variation of optical absorption coefficient along the 
depth and from the optical absorption coefficient, concentration of different chromophores can 
be recovered. The simplest case where 1D PA imaging can be applicable is the illumination of 
homogeneous, non-scattering optically absorbing material by an infinitely wide light beam of 
very short duration. The variation of the PA signal along the depth will follow the intensity 
variation of the incident light along the depth, given by Lambert Beer‘s law. The optical 
absorption coefficient can be calculated by finding out the slope of the exponentially decaying 
time dependent pressure data [4.13]. Guo et al., devised a frequency domain method for 
determining the optical absorption coefficient values along the depth. They acquired the PA 
signals at two different wavelengths, took Fourier transform of each of the PA signals and then 
fitted a curve governing by an Equation determined theoretically to the ratio of the magnitudes of 
the Fourier transforms of the PA signals. The advantage of working with the ratio of the Fourier 
transforms is that the Fourier transfer of the impulse response of the system, which remains the 
same irrespective of the wavelength change, cancels out in the ratio. They used this method in an 
OR-PAM set up to estimate absolute values of the absorption coefficients in a superficial vein 
and artery pair of a nude mouse ear obtained at 561 and 570 nm [4.14]. In case of multilayer 
media with different optical absorption coefficients corresponding to different layers, 
exponentials with different decay constants can be fitted to the parts of the curves corresponding 
to the separate layers. Karabutov et al. derived an expression to recover the absorption 
coefficient as a function of depth from the acquired PA data when the absorption coefficient of 




dependent absorption profiles for solutions of magnetite particles in oil [4.15]. Paultau et al. 
slightly modified this expression to account the diffraction effects and used it to find out the 
absorption profiles from the time dependent pressure signal for dyed gelatin phantoms [4.16]. 
For all the above three cases, it has been assumed that the medium is nonscattering. If scattering 
is considered, then the exponential decay of the fluence from the surface of a tissue will be 
governed by μt or μeff, not μa as mentioned in section 4.1. Due to backscattering, the maximum 
light fluence may occur not on the surface, but at a certain depth inside the tissue. Oraevsky et al. 
considered the effect of scattering and with the help of measured diffused reflected light from the 
surface, fitted an decaying exponential to the time dependent PA data to find the corresponding 
μeff. Then from the amplitude of the pressure data and recovered μeff, they found the 
corresponding values of μa, μs and g [4.17, 4.18]. For 1D methods to be applicable, the acoustic 
wave generated by the sample must be planar and perpendicular to z direction, the fluence 
distribution must remain constant in the X-Y plane and the optical properties of the material 
must also remain invariant in the X-Y plane [4.4]. Though for most of the practical situations, 
these conditions will not be satisfied, but the lack of complexity as well as the ease of 
computation involved with these methods makes them good approximations of the higher 
dimensional methods [4.4]. Laufer et al. used a 1D method to compute the blood oxygenation 
saturation fairly accurately [4.19]. 
Chromophore concentration from single point measurements: As mentioned earlier, there may be 
certain limitations associated with the 1D methods for optical property recovery from acquired 
PA signals. In actual tissue samples, the optical properties of the materials and the light fluence 
distribution in the X-Y plane will not be invariant. To overcome these difficulties partially, some 




separate single points. For these methods, the information is extracted separately for each point 
i.e. from each A-line PA signal corresponding to a particular tissue location. In a phantom study, 
Sivaramakrishnan et al. measured the blood oxygenation saturation from the PA signals at 
multiple wavelengths of a uniform cylindrical absorber of known size in a purely scattering 
medium. They proposed that under certain experimental conditions, the amplitude of the PA 
signal varies linearly with the optical absorption coefficient of the absorber [4.22 – 4.23]. Wang 
et al. measured total concentration of hemoglobin and hemoglobin oxygen saturation in rat brain 
vasculature from in vivo PAT images. They measured the transmitted light intensity through the 
skin and the brain of the rats ex vivo at two different wavelengths, used these measurements to 
calibrate the PA signals at the same two wavelengths and then used the calibrated PA signals to 
obtain the concentration measurements considering the PA signal varies linearly with absorption 
coefficient [4.24]. To measure the wavelength dependence of the light fluence inside the tissue 
under the same experimental conditions, Maslov et al. introduced a plain black absorbing film 
with a spectrally flat absorption coefficient inside the tissue at the same depth as that of the blood 
vessel, measured the PA signal due the black film to calibrate the PA signals from the blood 
vessels at different wavelengths and then used those calibrated PA signals to compute the blood 
oxygenation saturation [4.25 – 4.27]. Rajian et al. proposed to replace the film of black ink by an 
exogenous contrast agent for measuring the dependence of light fluence inside the tissue at 
different wavelengths [4.28]. Laufer et al. proposed a model based inversion technique to recover 
both optical absorption and scattering parameters of the material using prior knowledge of the 
shape and size of the tissue constituents. They built a phantom to mimic the real tissue and 
recovered the absorption and scattering coefficients from the point measurements using light 




generalized by using 3D acoustic propagation model and 2D PA images rather than a number of 
A-line PA signals to recover the quantitative estimates of hemoglobin and oxyhemoglobin 
concentration [4.30]. 
4.3.2 Procedure 
To recover the chromophore concentration, we adopted a method which suited with our 
experimental configuration and dimension of the tissue samples. The method was a fusion of the 
two approaches mentioned above.  Since all the tissue samples we imaged did not have 
significance thickness [most of the samples have thickness within 3 mm], we considered that the 
light fluence distribution inside the tissue in the X-Y plane is invariant as in 1D PA imaging 
approach. On the other hand, we assumed that the optical properties of the tissue sample will be 
different at different points as in single point measurements approach. Based on these two 
assumptions, we proposed that the amplitudes of the acquired localized PA signals at different 
points at a specific wavelength were proportional to the values of optical absorption coefficient 
at those particular points at that specific wavelength. Thus we modified Equation 4.7 to form 
Equation 4.8 by replacing μa(λ, x, y) with the acquired PA signal amplitude P
λ
(x ,y) for each 
point of measurement. 
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Here K is the proportionality constant which is related to ultrasound parameters and local optical 
fluence inside the tissue. Thus solving Equation 4.8, we recovered the concentrations of four 
different types of chromophores from five different C-mode images taken at five different 
wavelengths for one tissue sample. As mentioned earlier, since in the NIR wavelength region, 




are greater than that of other types of chromophores, so the concentrations of these four 
chromophores were recovered from the C-mode PA images. The five wavelengths at which the 
PA images of each sample were acquired are 760nm, 800nm, 850nm, 930nm and 970nm. 
 
Figure 4.6: Absorption spectra of chromophores (A) Absorption spectra of deoxyhemoglobin, 
oxyhemoglobin, (B) Absorption spectra of fat/lipid and water. Laser wavelengths, employed for 
acquiring PA images are shown by the dashed blue lines. [4.31] 
As it can be seen in Figure 4.6, the wavelengths have been selected in such a way that each 
wavelength matches with the corresponding wavelength at which one of the four chromophores 
has its peak specific absorption coefficient. The matched pairs of chromophore with its peak 
absorption coefficient wavelength are deoxyhemoglobin-760 nm, oxyhemoglobin-850 nm, fat-
930nm and water-970nm. The wavelength 800 nm has been selected as at this wavelength, the 
specific absorption coefficients of both deoxyhemoglobin and oxyhemoglobin are equal. 
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Now, as we can see from Figure 4.6, the values of specific absorption coefficients of 
deoxyhemoglobin and oxy hemoglobin are nearly two order of magnitude higher than that of 
lipid and water, so we recovered concentrations of deoxyhemoglobin and oxyhemoglobin only 
from the images taken at five wavelengths using a modified version of Equation 4.9.  























































































Similarly, we recovered the concentration of fat and water only from the five different C-mode 
images, since the specific absorption coefficient of fat and water are within the same range in the 
NIR region. For that, the modified version of Equation 4.9 is the following     

























































































4.3.3 Prostate Specimen Results 
 
Figure 4.7: Parametric images representing spatially varying chromophore concentration of a 
freshly excised human prostate tissue sample (A) Prostate tissue sample (B) Histology slide of 
the prostate tissue sample (C) Parametric image showing deoxyhemoglobin concentration (D) 
Parametric image showing oxyhemoglobin concentration (E) Parametric image showing lipid 
concentration (F) Parametric image showing water concentration. ROIs corresponding to the 
cancer tissue have been marked by the blue circles whereas the adjacent normal ROIs have been 
marked by the white circles in B, C, D, E and F. 
Figure 4.7A shows the photograph of a typical prostate specimen before the PA imaging was 
done. Figure 4.7B shows the digital histology slide of the prostate specimen in Figure 4.7A. 




images were created. The parametric images represent the varying chromophore concentration in 
the cross sectional plane as each pixel represents concentration of a certain chromophore at the 
corresponding spatial location in the tissue specimen. Four parametric images representing 
spatially varying concentration of deoxyhemoglobin, oxyhemoglobin, lipid and water are shown 
in Figure 4.7C – 4.7F. In Figure 4.7B – 4.7F, the ROIs corresponding to malignant prostate are 
shown using blue circles while the adjacent normal prostate regions are shown by white circles. 
Data from a total of 53 ROIs [collected from 30 patients] were analyzed. According to the 
histopathology analysis performed by the GU histopathologist, among the 53 ROIs, 19 ROIs 
were malignant, 8 ROIs were BPH and the rest of the ROIs were normal.           
Two sample two tailed t-test was performed with the chromophore concentration values 
extracted from the ROIs in the parametric images to find out whether there was statistically 
significant difference between chromophore concentrations corresponding to ROIs of different 
types. Figure 4.6 shows the results of the t-test performed at 5 % significant level with the 
chromophore concentration values corresponding to malignant vs. normal, malignant vs. BPH, 
BPH vs. normal and malignant vs. nonmalignant. The ROIs corresponding to BPH and normal 





Figure 4.8: Comparison of chromophore concentration between different prostate tissue types 
(A) malignant vs. normal (B) malignant vs. BPH (C) BPH vs. normal (D) malignant vs. 
nonmalignant using two sample two tailed t-test. The dashed lines show the levels corresponding 
to decision criterion (p = 0.05). 
From Figure 4.8, it can be seen that between malignant and normal prostate tissue, the 
chromophore concentration values are significantly different (p<0.05) for all of the four 
chromophores except water. Between malignant and BPH prostate, besides oxyhemoglobin and 
lipid, chromophore concentration values are significantly different (p<0.05) for other 
chromophores. For BPH vs. normal prostate and malignant vs nonmalignant, only water 
concentration is not significantly different (p>0.05).  
Two way ANOVA test was performed with the chromophore concentration values considering 




groups of tissue namely cancer, benign and normal, while chromophore type consists of 
deoxyhemoglobin, oxyhemoglobin, lipid and water. 
Table 4.2: Two way ANOVA test results for chromophore concentration values between 









F p value 
Tissue category 18.15 2 9.074 23.07 1.12233e-10 
Chromophore 305.36 3 101.787 258.85 1.80038e-150 
Tissue 
category*chromophore 
65.87 6 10.979 27.92 1.12749e-32 
Error 1264.63 3216 0.393   
Total 1701.19 3227    
 
Results of the two way ANOVA test shows that means of chromophore concentration values are 
significantly different between different tissue types as the corresponding p value is very small 
[1e-36] and chromophore concentration means are also significantly different between different 
chromophore types [p value = 2e-150]. As the p value corresponding to interaction term is very 







4.3.3 Thyroid Specimen Results 
Figure 4.9A shows the photograph of a typical thyroid specimen before the PA imaging was 
done. Figure 4.9B shows the scanned histology slide overlaid on the image of the thyroid 
specimen. Using recovered spatially varying chromophore centration, parametric images were 
created. The parametric images represent the varying chromophore concentration with a cross 
sectional view as each pixel represents concentration of a certain chromophore at the 
corresponding spatial location in the tissue specimen. Four parametric images representing 
spatially varying concentration of deoxyhemoglobin, oxyhemoglobin, lipid and water are shown 
in Figure 4.9C – 4.9F. In Figure 4.9B, malignant region was marked with blue ink by the 
pathologist. In Figures 4.9C – 4.9F, the ROIs corresponding to malignant thyroid are shown 








Figure 4.9: Parametric images representing spatially varying chromophore concentration of a 
freshly excised human thyroid tissue sample; (A) Thyroid tissue sample (B) Histology slide of 
the thyroid tissue sample overlaid on the thyroid specimen image (C) Parametric image showing 
deoxyhemoglobin concentration (D) Parametric image showing oxyhemoglobin concentration 
(E) Parametric image showing lipid concentration (F) Parametric image showing water 
concentration. ROIs corresponding to the cancer tissue have been marked by the blue circles in 
B, C, D, E and F. 
Two sample two tailed t-test was performed with the chromophore concentration values 
extracted from the ROIs in the chromophore concentration parametric images to find out whether 
there was statistically significant difference between chromophore concentrations corresponding 
to ROIs of different types. Figure 4.10 shows the results of the t-test performed at 5 % significant 
level with the values of the parameter corresponding to malignant vs. normal, malignant vs. 
benign, benign vs. normal and malignant vs. nonmalignant thyroid tissue. The ROIs 





Figure 4.10: Comparison of chromophore concentration between different thyroid tissue types 
(A) malignant vs. normal (B) malignant vs. benign (C) benign vs. normal (D) malignant vs. 
nonmalignant using two sample two tailed t-test. The dashed lines show the levels corresponding 
to decision criterion (p = 0.05). 
From Figure 4.10, it can be seen that between malignant and normal thyroid tissue, the 
chromophore concentration values are significantly different (p<0.05) for all of the four 
chromophores. Between malignant and benign thyroid, besides oxyhemoglobin and lipid, 
chromophore concentration values are significantly different (p<0.05) for other two 
chromophores. For benign vs. normal and malignant vs. nonmalignant thyroid tissue, all of the 






CHAPTER 5: Feature Extraction from Frequency Domain PA Signal 
5.1 Modeling of 1D PA Signals 
A detail study of the temporal characteristics of the photoacoustic waves, generated by different 
absorbers following absorption of short pulse laser light is extremely important for PA image 
analysis. In this study, features were extracted from 2D C-scan PA image pixels as well as time 
dependent PA A-line signals corresponding to different tissue pathologies. As it has been proved 
that, temporal features and corresponding frequency contents of the PA signals depend on the 
geometries of the particular PA absorbers [5.1], modeling of PA signals generated by different 
types of PA absorbers can help to obtain a preliminary idea about the relationships between the 
temporal and spectral features of PA signals with the corresponding absorber geometries. 
Studying the modeled PA signals and corresponding frequency contents, the impact of the 
limited bandwidth of the detection system [transducers] on the detected PA signals can also be 
understood. Detail discussions about the physics of PA effect and PA wave generation are 
available in literature [5.1 – 5.5]. 
Here time dependent PA signals generated by absorbers of various different geometries have 
been modeled. The PA signals have been modeled using the expressions generated by Diebold et 
al. [5.1 – 5.3]. The frequency contents of the PA signals have been also computed. 
The increment of pressure in a tissue like medium due to the localized heating produced by the 
absorption of light energy, is given by Equation 5.1. 
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β is the isobaric volume expansion coefficient, ΔT is the temperature increment, V is the original 
volume and ΔV is the volume increment [5.4]. 
Now from the above equation it is apparent that the value of p will be maximum when there will 
be no volume increment i.e. ΔV will be zero. This is known as stress or inertial confinement. The 
stress confinement can be achieved if the pulse duration of the incoming laser light is much 
smaller than the characteristics time for acoustic relaxation, tac , given by Equation 5.2. 
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Here c is the speed of the acoustic wave inside the tissue and µa is the absorption coefficient of 
the tissue [5.4]. If the stress confinement condition is satisfied then the shape of the excited 
acoustic wave follows the spatial distribution of the heat source [5.2]. 
The thermal relaxation time tth is given by Equation 5.3. 




tht                                                                   5.3 
Here χ is the thermal diffusivity of the medium.                                                               
Generally the value of tth is larger than tac i.e. the thermal relaxation takes place much slowly 
than the acoustic relaxation. So, if the incoming laser pulse satisfies the stress confinement 
condition, then it is bound to satisfy the thermal confinement condition. The thermal 
confinement condition ensures that heat generated by the absorption of laser light will be 





The temporal evolution of the thermoelastic stress i.e. the stress generated due to heat produced 
by the absorption of the laser light, contains two distinct stages. In the first stage, the maximum 
stress p=BβΔT, has been generated under stress confinement condition. In the second stage, the 
forces caused by the thermal stress lead to the displacements which propagate as the broadband 
longitudinal acoustic waves through the medium [5.4]. 
The coupling equations, describing the temperature and pressure perturbations due to the 
photoacoustic wave, can be derived from the linearized mass, momentum and energy 
conservation equations. As described earlier, under the condition tth >> tac, the two coupling 
equations can be merged together to form the following photoacoustic wave equation [5.2]. 


















                                                     5.4 
Here, H is the heat deposited in the medium per unit volume per unit time and Cp is the heat 
capacity per unit mass. 
For 1D PA wave, the Laplacian operator in Equation 5.4 reduces to the second derivative with 
respect to z, the direction of propagation of the photoacoustic waves. Using a suitable Green‘s 
function, the solution for the 1D version of Equation 5.4 can be expressed as Equation 5.5. 




















                                                 5.5 
Here the source of the PA wave is at the origin and the field point (0, 0, z) is any point located on 
the positive Z axis away from the source. 
Now, if we consider that the PA wave is generated due to the absorption of pulsed laser light of 
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Here E0 is the energy per unit area in the laser beam or energy fluence and  zh ˆˆ  is the 
dimensionless function which describes the spatial deposition of energy arising from the 
absorption of the input laser light. 
Equation 5.5 can be solved using Equation 5.6 and the solution can be expressed as Equation 5.7 




































a                         5.7  
Here ξ is a generalized coordinate (ξ = z in one dimension and ξ = r in three dimension) and ξ0 is 
a constant. Equation 5.7 shows that under the condition of stress confinement which is satisfied 
here since input laser pulses are of nanosecond duration, the spatial deposition of heat in the 
medium from a short pulse laser source is followed by the time profile of the photoacoustic 
wave. The factor 2 in the numerator has been introduced to take care of the fact that the initial 
pressure will be equally distributed to the two waves propagating along the positive Z axis and 
negative Z axis. 
The thermo-acoustic pressure wave generation efficiency can be expressed by a dimensionless 
parameter Γ, which is defined by Equation 5.8. 
                                                                 p
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Using equation 5.7, expressions for initial PA pressure generated by absorbers of different 
geometries following uniform illumination of short duration [nanosecond] pulsed laser light, can 




5.1.1 Thin Layer 
The pressure generated at the field point z on the Z axis due to uniform absorption of pulse laser 
light by a vanishingly thin layer of high absorbing material is given by Equation 5.9. 


































̂                                                               
Here z0 is the distance of the thin layer from the origin. The thin layer is perpendicular to the Z 
axis. 
Similarly, the pressure generated at the field point (0, 0, z) due to the absorption of infinitely 
wide beam of light by a thin layer of absorbing material of thickness z0, placed perpendicular to 
the z axis and having infinite dimensions along X & Y axes, is given by Equation 5.10. 
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The starting edge of the thin layer coincides with the origin. Here only the wave propagating 
along positive Z axis has been considered because, the portion of wave propagating along 
negative Z axis will not reach the filed point. . The starting edge of the thin layer coincides with 
the origin. The exponential term has been introduced in the expression to take care of the decay 





Figure 5.1: PA signal for a vanishingly thin high absorbing layer placed at a distance 0.5 cm 
from the origin (a) Initial PA signal (B) Amplitude spectrum of the initial PA signal. 
Figure 5.1 shows the PA signal generated by a vanishingly thin absorbing layer, placed at z0 = 
0.05 cm. The field point was at z = 0.5 cm. The amplitude spectrum of the PA signal generated 
was shown in Figure 5.1 B. As the PA signal is a delta function, the corresponding amplitude 






Figure 5.2: PA signal generated by a thin film of thickness 0.05 cm (a) Initial PA signal (B) 
Amplitude spectrum of the initial PA signal. 
Figure 5.2 shows the PA signal generated by a thin film of thickness 0.05 cm. The field point 
was at z = 0.5 cm. Figure 4.5B shows the corresponding amplitude spectrum. 
For generating both Figure 5.1 and 5.2, following material properties were assumed. 
 μa = 0.6 cm
-1
 and Γ = 0.8. 
 The incident laser fluence E0 was assumed to be unity. 
5.1.2 The Sphere 
Equivalent form of equation 5.5 can be found and solved in three dimensions to find the 
properties of the photoacoustic wave generated due to absorption of pulsed laser light by a 




to absorption of light by a spherical shell can also be found. When the source is a spherical shell, 
then the expression of the pressure generated is given by Equation 5.11. 
                            
































̂                                 5.11 
Here, r0 is the radius of the spherical shell and r is the field point or the point of observation. 
The expression of pressure for a uniformly irradiated sphere is given by 












r                                        5.12 
Using Equations 5.11 and 5.12, the PA waves generated by uniformly illuminated spherical shell 
and spherical droplet were simulated and the results are shown in Figure 5.3 and 5.4. The radii of 
the spherical shell and the sphere were 0.05 cm. Field points for both the cases were at 0.5 cm. 
The material properties considered for the two cases were following 
μa = 0.6 cm
-1
 and Γ = 0.8. 





Figure 5.3: PA signal generated by a uniformly irradiated spherical shell of radius 0.05 cm (a) 
Initial PA signal (B) Amplitude spectrum of the initial PA signal. 
 
Figure 5.4: PA signal generated by a uniformly irradiated sphere of radius 0.05 cm (a) Initial PA 






5.1.3: The Cylinder 
The expression for PA wave generated by a cylindrical absorber, uniformly irradiated by pulsed 
laser light is given by Equation 5.13.  
 
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t   
ρ0 is the radius of the cylinder. Equation 5.13 was evaluated by performing numerical integration 
using Bode‘s rule [5.6] to model the PA wave generated by a cylinder with radius 0.05 cm. The 
field point or the point of observation was ρ = 0.5 cm. Figure 5.5A shows the PA signal 
generated by the cylinder while Figure 5.5B shows the corresponding PA amplitude spectrum. 
The material properties of the cylinder was following 
μa = 0.6 cm
-1
 and Γ = 0.8. 





Figure 5.5: PA signal generated by a uniformly irradiated cylinder of radius 0.05 cm (a) Initial 
PA signal (B) Amplitude spectrum of the initial PA signal. 
The amplitude spectrum was modeled according to the analytical expression given in Equation 
5.14 [5.3]. 
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t   where ω is the angular frequency. d̂ and ĉ represent the ratio of 
densities and velocities of sound inside and outside of the cylinder. J and H represent Bessel 
function and Hankel function. The subscript for J represents the order of the Bessel function 
whereas the subscript and superscript within parenthesis for H represent the order and kind of the 
Hankel function respectively. 




Using these models, a clear idea can be obtained about how the geometry of different absorbers 
affect temporal features and corresponding frequency content of the generated PA signals. These 
models were the foundation of the extensive simulation study performed later [section 5.2.2] to 
find out the capability of the frequency analysis technique for our limited bandwidth PA 

















5.2 Frequency Domain Analysis 
As the spectrum of Photoacoustic (PA) radio frequency (RF) signals contain significant 
information about the structure of PA absorbers, parameters extracted from PA spectrum can be 
potentially used to differentiate between different tissue pathologies. Quantitative reconstruction 
of chromophore concentration or optical properties of soft tissue from the multispectral PA 
image pixels is very difficult as the pixel values depend on several factors like the optical 
absorption and scattering inside the tissue, frequency dependent acoustic attenuation etc. 
Although there are several methods proposed by different research groups for quantitative 
recovery of absorption property and chromophore concentration, some of the methods can be 
applied to only specific cases i.e. their application is limited by the assumption on which they 
have been built, while the more general methods have been tested only in simulation [5.7]. An 
alternative approach for tissue characterization using PA data is the analysis of the PA frequency 
spectrum as it carries significant information about the shape and size of the PA absorbers [5.2]. 
5.2.1 Literature Review 
Frequency domain analysis in which spectral parameters namely slope, midband fit and intercept 
are extracted from the power  spectra of the time dependent signals in the usable bandwidth is a 
widely used technique in pulse echo US imaging for tissue characterization [5.8, 5.9]. 
Application of this technique on the PA image data is more recent. Using frequency domain 
analysis on high frequency PA signal generated by ex-vivo ocular tissue, Silverman et. Al. [5.10] 
found that spectral slope and midband fit parameters were higher around iris pigment epithelium. 
Kuman et al. [5.11] implemented frequency domain analysis technique in an in vivo PA imaging 
study with prostate cancer murine model involving 7 rats and they showed that midband fit and 




a phantom study, slope values corresponding to two different diameter microsphere distribution, 
were shown to be significantly different from each other by Yang et al. [5.12]. Using a 
simulation study, a series of hypothesis relating the size and distribution of the spherical PA 
absorbers with extracted PA spectral parameters was derived by Xu et al. [5.13] and they 
validated those hypotheses using a phantom study. Hysi et. al. [5.14] studied the change in PA 
spectral parameters with the change of Red Blood cell (RBC) aggregation and oxygenation using 
experimentally acquired PA signal generated by Porcine RBCs along with a Monte Carlo based 
theoretical model. In a phantom study with microspheres, Chitnis et al. [5.15] investigated the 
effect of effective absorber size extracted from the high frequency PA spectrum, slope and 
midband fit on the mean absorber diameter of the microspheres. Xu et al. [5.16] performed ex-
vivo as well as in situ experiments on mouse models to investigate the feasibility of 
differentiating fatty liver from normal liver using PA spectral parameters. Although the 
frequency domain analysis is not entirely independent of light absorption and scattering inside 
the overlying tissue, we postulate that it may provide additional information about the dimension 
of PA absorbers and that information may be used to differentiate different tissue pathologies. 
This study presents the results of moderately large scale studies of frequency analysis of PA 
signal data collected from freshly excised human prostate and thyroid tissue samples.  What is 
unique about this work is that the experimental study was preceded by a detailed simulation 
study in which the system specific [for the limited bandwidth system which was used to acquire 







5.2.2 Simulation Study 
The overall goal of the simulation study was to assess the utility of the power spectrum analysis 
of PA signal captured by our low frequency limited bandwidth system and thereby validate the 
use of power spectrum analysis on the PA data accumulated on ex vivo specimens. The 
simulation study was divided into three parts. In PA absorber radius range, the range of the 
radius of the spherical PA absorbers for which the power spectrum analysis is appropriate to 
perform, was determined. This range of radius or limitation on the value of the radius of the PA 
absorber is due to the finite usable bandwidth [2.4 MHz – 7.4 MHz] of our PA imaging system. 
The usable bandwidth is the frequency range within -10 dB of the peak of one way transducer 
power spectrum. In Spectral parameter relationship with absorber radius, we investigated the 
relationship of the spectral parameters with mean radius within the predetermined radius range. 
In Resolving power of the power spectrum analysis, we performed statistical analysis to 
investigate whether the spectral parameters are significantly different for absorbers with different 
radius. We used spherical PA absorber for the simulation study as it is easier to simulate time 
domain PA signals generated by spherical absorbers than cylindrical absorbers. The frequency 
spectrum of PA signal generated by a spherical absorber is similar to that of a cylindrical 
absorber. 
 PA absorber radius range: To determine the range of radius of the spherical absorbers we 
studied amplitude spectrum of the PA signal generated by the spherical absorbers. The time 
dependent PA signal generated by a spherical absorber is given by [5.2] 
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heat capacity per unit mass of the spherical PA absorber, while c and E0 represent the velocity of 
PA wave inside the absorber and input laser fluence received by the absorber. Radius of the 
absorber and the distance between the observation point and the center of the absorber are 
represented by r and rd. The time dependent PA amplitude is represented by p(t). The amplitude 
spectrum of the PA signal can be found out by taking Fourier transform of Equation 5.15. 
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Here P(f) represents the amplitude spectrum of the time dependent PA signal  The power 
spectrum of the PA signal in dB scale is given by Equation 5.17.   
                                                         
)(log20 10 fPpdB                                                          5.17  
 
Figure 5.6: (A) Normalized Amplitude spectrum of PA signal generated by spherical absorbers 




Figure 5.6 shows the normalized power spectrum of the PA signal generated by spherical 
absorbers of different radii. It can be seen that with the increase of the radius, width of the 
primary lobe decreases and vice versa.  As linear regression was to be performed for extracting 
spectral parameters so the power spectrum analysis would be appropriate only when 
approximately linear region of the power spectrum fell within the usable bandwidth. We 
observed the approximate linearity was preserved only up to the third minimum of the power 
spectrum. So we hypothesized that linear regression will be appropriate to perform provided that 
portions of the power spectrum beyond the third minimum do not fall within the usable 
bandwidth. To further support our hypothesis, we calculated R
2
 value [100 x R
2
] corresponding 
to the linear regression. The R
2
 value is a general indicator of how much a regression model can 
be improved [5.17].  It was observed that the R
2
 value degraded significantly if portions beyond 
the third minimum were considered for linear regression. This criterion set the higher limit on the 
radius of the spherical absorber. We found that, for our system, power spectrum analysis might 
be appropriate to perform for PA absorbers of radius up to 240 µm. Furthermore, the frequency 
corresponding to the peak of the primary lobe shifted to lower values with increasing radius. This 





Figure 5.7: (A) Power spectrum of 240 µm spherical absorber within usable bandwidth, (B) 
Power spectrum of 280 µm spherical absorber within usable bandwidth. 
Figure 5.7 shows frequency spectrums corresponding to PA absorbers of radii 240 µm and 280 
µm. Figure 5.7A shows the power spectrum generated by PA absorber of 240 µm radius with the 
straight line which is best fit to the power spectrum in the usable bandwidth. The two vertical 
lines designate the usable bandwidth [2.4 MHz – 7.4 MHz]. It can be seen that the third 
minimum point coincides with the maximum frequency in the usable bandwidth. Figure 5.7B 
depicts the same as Figure 5.7A for a PA absorber having 280 µm radius. The R
2
 value 
corresponding to the linear regression degrades significantly [From 26.7 to 11.7] for power 
spectrum of 280 µm PA absorber.  
For determining the lower limit on the PA absorber radius, we inspected the best fit straight lines 
to the corresponding power spectrums. When the radius of the PA absorber is below a certain 
limit, then slope of the best fit straight line changes sign i.e. it becomes positive from negative 
value. While working with the PA signals generated by the actual tissue samples, we obtained 
negative slope values for all the cases. This prompted us to ignore the positive slope values and 




radius of the PA absorbers should be the value below which the corresponding slope value 
becomes positive. We found that for our system, for a PA absorber having radius below 88 µm, 
the corresponding slope value became positive. So the lower limit on the radius of PA absorber 
for which the power spectrum analysis is appropriate to apply is 88 µm. 
 
 
Figure 5.8: Power spectrum with the best fit straight line in the usable bandwidth for (A) PA 
absorber with 88 µm radius (B) PA absorber with 87 µm radius. Slope value for (A) is -1.08 
dB/MHz and for (B) is 0.23 dB/MHz. 
Figure 5.8 shows the power spectrum with the best fit straight lines in the usable bandwidth 
corresponding to PA absorbers of 88µm and 87 µm radii. The slope is negative valued [-1.08 
dB/MHz] for 88 µm absorber while it becomes positive [0.23 dB/MHz] for 87 µm. For radii 
greater than 88 µm, the major portion of the usable bandwidth remains on the right of the first 
maximum of the corresponding power spectrum which may be the probable reason for the 
negative slope of the best fit straight line. For radii below 87 µm the major portion of the usable 
bandwidth shifts to the left of the first maximum of the corresponding power spectrum and so the 




considering the predominant sign of the slope for the tissue specimens, we believe the 
appropriate range of radii for applying power spectrum analysis on the PA signals generated by 
the spherical PA absorbers is from 88µm to 240 µm. 
Spectral parameter relationship with absorber radius: Here we investigated the relationship of the 
spectral parameters with the absorber radii in the radius range determined earlier. We 
hypothesized that a ROI corresponding to any particular type of tissue pathology contains light 
absorbers whose radii follow a certain statistical distribution around a particular mean value. In a 
previous simulation study [5.13], relationship among spectral parameters and absorber radius 
was established for PA absorbers of same radius, spatially distributed over a certain volume 
following a uniform random distribution. For our simulation study, we assumed that the radii of 
the absorbers follow Gaussian distribution around a particular mean value with a given standard 
deviation. To negate the effect of the spatial position of the absorbers, we considered all the 
absorbers had identical positions with respect to the point of observation. Also to make the study 





Figure 5.9: Flowchart for the simulation study of the power spectrum analysis on PA signal 
generated by Spherical absorbers 
The steps of the simulation study, as shown in Figure 5.9, are described below. 
Radius selection: The radii of the spherical absorbers were sampled randomly from a Gaussian 
distribution with a certain mean and standard division. The standard deviations were chosen as 
one fourth of the corresponding mean values.   
PA signal Simulation: Time dependent 1D PA signal generated by a spherical PA absorber after 
irradiated with a short duration (nanosecond) laser pulse was simulated according to Equation 
5.15. Figure 5.10A and Figure 5.10B show the simulated PA signal generated by a spherical PA 





Figure 5.10: (A) Simulated PA signal due to a spherical absorber of 150 µm radius (B) 
Amplitude spectrum of the PA signal shown in Figure 5.10A. 
Noise Addition: Once the PA signal was simulated, white noise was added to the signal. For 
choosing appropriate signal to noise ratio (SNR), a number of PA signals, generated by the real 
tissue samples were inspected and the minimum SNR among them was found out. The SNR of 
white noise added to the simulated PA signal was chosen as equal to the minimum SNR [10] of 
real tissue PA data. For determining noise type, noise present in PA signals generated by real 
tissue was inspected and it was found that they were best resembled by the white noise. Figure 
5.11A shows white noise added to the simulated PA signal in Figure 5.10A while Figure 5.11B 





Figure 5.11: (A) Noisy PA signal simulated by adding white noise to PA signal in Figure 5.11A, 
the signal to noise ratio is 10 (B) Amplitude spectrum of the PA signal shown in Figure 5.11A. 
Linear Regression: Fast Fourier Transform (FFT) based power spectrum of simulated PA signal 
was computed. Linear regression was performed to find the straight line best fit to the portion of 
the power spectrum in the usable bandwidth. Figure 5.12A shows the power spectrum of the 
noisy PA signal shown in Figure 5.11A. The vertical straight lines indicate the usable bandwidth 
of our PA imaging system. 
Parameter extraction: Three parameters namely, slope (dB/MHz), midband fit (dB) and intercept 
(dB) were extracted from the best fit straight line. Slope and intercept are the slope and intercept 
of the straight line while midband fit is the y-coordinate of the point on the straight line 
corresponding to the middle frequency [5 MHz] in the usable bandwidth. Figure 5.12B shows the 





Figure 5.12: (A) Power spectrum of the noisy PA signal shown in Figure 5.11A, the vertical 
dashed line indicate the usable bandwidth [2.4 MHz – 7.4 MHz] of our PA imaging system (B) 
Power spectrum with the best fit straight line in the usable bandwidth. The values of slope, 
midband fit and intercept, extracted from the straight line are respectively -2.21 dB/MHz, -14.10 
dB and -3.08 dB. R
2
 value corresponding to the linear regression in Figure 5.12B is 33.91. 
The complete process is performed for a significant number of radius values (N = 100) sampled 
from a specific normal distribution with given mean radius. Corresponding to each sampled 
radius value, a set of values for the three spectral parameters was obtained. Each parameter was 
averaged over N values to obtain one final parameter value corresponding to the given mean 
radius. 
We performed the simulation study with several Gaussian distributions of radius values. Each 
mean radius value was within the range of radius appropriate for our PA system. Figure 5.13 
shows the results of the simulation study performed with mean radii 100 µm, 130 µm, 160 µm, 
190 µm, 210 µm, and 240 µm. For each mean radius, the corresponding standard deviation is one 





Figure 5.13: Mean spectral parameters against the mean radius (A) Slope [dB/MHz] against 
mean radius [µm] (B) Midband fit [dB] against mean radius [µm] (C) Intercept [dB] against 
mean radius [µm]. Standard deviation of each parameter over N = 100 are the corresponding 
error bars. 
In Figure 5.13 the three spectral parameters, averaged over N = 100, were plotted against the 
mean radii of the spherical PA absorbers. According the hypotheses of Xu et al. [5.13], the slope 
should decrease while intercept and midband fit parameters should increase with increasing 
radius of PA absorber. Figure 5.13A shows that, besides the last two points, average slope 
decreases almost consistently with the increasing mean radius. Figure 5.13C shows that intercept 
increase almost consistently with the mean radius apart from the last two radius values, while 
Figure 5.13B shows that midband fit increase consistently for all mean radii. We assumed that 
the departure of mean slope and intercept from the expected trend for the last two points i.e. 
when mean radius was equal to 210 µm and 240 µm, was due to the fact that that those mean 






Figure 5.14: Average amplitude spectrum and best fit straight lines or linear models having 
average spectral parameters corresponding to different mean radii. 
Figure 5.14 shows the mean amplitude spectra corresponding to different Gaussian distributions 
of radius values. The linear models or best fit straight line were plotted using the average spectral 
parameters corresponding to each mean radius. 
Resolving power of the power spectrum analysis: Here, we examined the potential of the power 
spectrum analysis to differentiate between PA absorbers of different radii. Two sample two tailed 
t tests were performed with spectral parameters corresponding to Gaussian distributions of radius 
values with different mean radii. Within  the appropriate radius range [88 µm – 240 µm], equally 
spaced mean radius values were chosen and spectral parameters corresponding to radius values 
sampled randomly from normal distributions around the mean radii were computed in the 
presence of noise. Two sample two tailed t tests were performed to test whether the spectral 




started with large gap between the successive mean radius values (40 µm) and gradually 
decreased the gap to 10 µm. In this way, we tried to find out the smallest difference between the 
mean radii of two different types of PA absorbers for which the corresponding spectral 
parameters would be significantly different. Or in other words, we tried to measure the resolving 
power of the power spectrum analysis to differentiate among different spherical PA absorbers 
within the appropriate radius range. 
 
Figure 5.15: Two sample two tailed t test performed with the spectral parameters corresponding 
to different mean absorber radii. The red line is the significance level corresponding to p = 0 05. 





Figure 5.15 shows the results of the two sample two tailed t test. The red line shows the chosen 
significance level p = 0.05. So for any p value higher than the significance level, the 
corresponding spectral parameter is significantly different between the corresponding radius pair. 
When the difference between the successive mean radii was large (40 µm in Figure 5.15A), the 
corresponding spectral parameters were significantly different for almost all the cases. When the 
difference between the successive radii was reduced to minimum (10 µm in Figure 5.15D), 
spectral parameters for most of the cases were not significantly different. When the difference 
was 30 µm, the spectral parameters for majority of the mean radius pairs were significantly 
different (Figure 5.15C). So, it can be said, for our PA system, the power spectrum analysis can 
differentiate between two different PA absorbers when their radii differ by at least 30 µm, 
provided the radii are within the appropriate range.  
5.2.3 Frequency Domain Analysis of Tissue Generated PA Data 
Frequency domain analysis was performed on 3D PA data generated by excised human prostate 
and thyroid specimens collected from patients undergoing surgery for suspected prostate or 
thyroid cancer. The objective of this study was to verify the feasibility of differentiating among 
malignant, benign and normal prostate/thyroid tissue using frequency domain analysis of the 3D 





Figure 5.16: Flowchart of experimental study. 
Figure 5.16 shows different steps of the experimental study. 
The PA data acquisition and ROI selection process have been explained in detail in Chapter 3. 
Power spectrum calculation of the windowed PA signals: Once ROI selection was completed; 
power spectra of the preprocessed and windowed PA A-line signals within the ROI were 
computed. In this step, the PA A-line signals were corrected for the wavelength dependent laser 
input intensity variation using the input laser intensity measurements taken prior to each 
experiment. Then wavelength dependent attenuation of laser light during its propagation inside 
the prostate tissue was corrected for prostate specimens. The laser light gets attenuated while 
propagating through the tissue due to the optical absorption and scattering properties of the 
tissue. Using Lambert Beer‘s law, 1D light attenuation was computed along the depth (Z axis) 
inside the tissue for the five different wavelengths and these computations were used to correct 
the PA A-line signals for the light attenuation at different depths inside the tissue. 
                                 




Equation 5.18 represents the Lambert Beer‘s law used to compute the light attenuation inside the 
tissue along the depth. Here µeff, µa, and µs
/
 are the effective attenuation coefficient, absorption 
coefficient, and reduced scattering coefficient of the tissue. Φz and Φ0 are respectively the light 
fluence at depth z inside the tissue and at the surface of the tissue. The values of the effective 
optical attenuation at five different wavelengths were calculated using the corresponding values 
of µa, and µs
/
 as reported for human prostate [5.18]. The different values of  µeff used here were 
1.91 cm
-1
 at 760 nm, 1.79 cm
-1
 800 nm, 2.01 cm
-1
 850 nm, 2.14 cm
-1
 930 nm and 2.71 cm
-1
 at 
970 nm. For thyroid specimens, no correction was performed for depth dependent laser light 
attenuation inside tissue, as µeff values at multiple wavelengths could not be found.  Once these 
corrections were done, the PA A-line signals were time-gated to small sections using a series of 
sliding Hamming windows. For determining the width of the Hamming window, the results from 
the simulation section were used. We hypothesized that the window should be long enough to 
accommodate at least one PA absorber. As found out from the simulation study, for our system, 
the power spectrum analysis can be applied successfully for spherical PA absorbers having radii 
up to 240 µm. The time duration of resulting signal obtained after convolving PA signal 
generated by a PA absorber of 240 µm radius and the impulse response of the our transducer 
array is approximately equal to 1 µs. So a series of Hamming windows having 1 µs length were 
employed here. During windowing, 30% overlap between Hamming windows on successive 
segments of every A-line was used as a compromise between reducing truncation artifacts in 
FFT and minimizing overlap.  Power spectrum of each time gated A-line PA signal was 





Parameter extraction from the calibrated power spectrum: Each computed power spectrum was 
divided by the one way power spectrum of the transducer array to remove the artifacts due to the 
finite bandwidth of the transducer. The one way power spectrum of the transducer array was 
calculated using the two way [pulse echo] transfer function of the transducer array provided by 
the manufacturer. The calibrated power spectrum was converted to dB scale. Linear regression 
was performed to find the straight line best fit to the calibrated power spectrum in the usable 
bandwidth. The three spectral parameters, slope [dB/MHz], midband fit [dB] and intercept [dB] 
were extracted from each best fit straight line [5.19, 5.20]. 
 
 
Figure 5.17: Example of power spectrum analysis on single PA A-line signal (A) C-scan image 
PA image of a typical excise prostate specimen (B) Normalized PA A-line signal generated by 
the tissue corresponding to the blue colored pixel in 5.17A (C) Power spectrum of the windowed 
PA A-line signal along with one way power spectrum of the transducer (both normalized before 
conversion to dB scale) in the useable bandwidth region, the vertical dashed lines represent the 
boundaries of the usable bandwidth [2.4 MHz – 7.4 MHz] (D) Calibrated power spectrum fitted 
to the linear model.  
Figure 5.17 shows an example of the power spectrum analysis applied on a particular PA A-line 




pixel in the C-scan image corresponds to a PA A-line signal. In Figure 5.17B, the PA A-line 
signal corresponding to the pixel marked by blue color in Figure 5.17A is shown. Figure 5.17C 
shows the power spectrum of the PA A-line signal and the one way power spectrum of the 
transducer. Figure 5.17D shows the straight line fitted with the portion of the calibrated power 
spectrum in the usable bandwidth. As mentioned in the simulation section, spectral parameters 
slope and intercept are the slope and intercept of the straight line while the midband fit is the 
height of the straight line at 5 MHz. 
Statistical analysis of the extracted parameters: Two sample two tailed t-test were performed 
with the extracted spectral parameters to test whether the spectral parameters were significantly 
different between malignant and normal ROIs, normal and benign ROIs, malignant and benign 
ROIs, malignant and nonmalignant ROIs for each of the five wavelengths. For each type of ROI 
[malignant, benign, normal & nonmalignant], average values of the spectral parameters were 
computed and plotted against the five wavelengths. 
5.2.4 Prostate Specimen Results 
For prostate data analysis, 30 Patients were involved in this study. Data from a total of 53 ROI 
were analyzed. According to the histopathology analysis performed by the GU histopathologist, 
among the 53 ROIs, 19 ROIs were malignant, 8 ROIs were BPH (Benign Prostate Hyperplasia) 
and the rest of the ROIs were normal.           
The mean values of the three parameters corresponding to three different types of ROIs were 
plotted against the wavelengths in Figure 5.18. The mean values were computed over the 
respective number of ROIs that were included into the study corresponding to cancer, BPH and 
normal prostate tissue. At each point in all the plots, the error bar and the circle represent the 




of ROIs. The ROIs corresponding to BPH and normal prostate tissue were grouped into 
‗nonmalignant‘ category and the mean values of the three parameters corresponding to 
nonmalignant and malignant ROIs were plotted against wavelengths in Figure 5.19. 
 
Figure 5.18: Plot of average values of the three parameters corresponding to different ROIs 
against five different wavelengths (A) Mean slope vs. wavelength (B) Mean midband fit vs. 
wavelength; (C) Mean intercept vs. wavelength. The error bar at each point is the standard 
deviation of the corresponding parameter over the respective number of ROIs. Circles represent 
median values of the parameters. 
 
Figure 5.19: Plot of average values of the three parameters corresponding to nonmalignant and 




midband fit vs. wavelength; (C) Mean intercept vs. wavelength. The error bar at each point is the 
standard deviation of the corresponding parameter over the respective number of ROIs. Circles 
represent median values of the parameters. 
Two sample two tailed t-test was performed with the parameter values to find out whether there 
was statistically significant difference between the parameters corresponding to ROIs of different 
types. Figure 5.20 shows the results of the t-test performed at 5 % significant level with the 
values of slope, midband fit and intercept corresponding to malignant vs. normal, malignant vs. 
BPH, BPH vs. normal and malignant vs. nonmalignant. 
 
Figure 5.20: Comparison of spectral parameters between different prostate tissue types (A) 
malignant vs. normal (B) malignant vs. BPH (C) BPH vs. normal (D) malignant vs. 
nonmalignant using two sample two tailed t-test. The red lines show the levels corresponding to 




From Figure 5.20, it can be seen that between malignant and normal prostate tissue, the spectral 
parameters are significantly different (p<0.05) except for the slope at 930 nm and 970 nm. 
Between malignant and BPH prostate, besides slope at 800 nm and intercept at 760nm and 970 
nm, the three spectral parameters are significantly different (p<0.05). For BPH vs. normal 
prostate, intercept at 930 nm and slope at 760nm, 850 nm, 930 nm and 970 nm are not 
significantly different (p>0.05) while between malignant and nonmalignant prostate, slope at 930 
nm is not significantly different (p>0.05).  
Two way ANOVA tests were performed with the three spectral parameters considering tissue 
category and wavelength as two predictors. Tissue category contains three separate groups of 
tissue namely cancer, benign and normal, while wavelength consists of 760 nm, 800 nm, 850 nm, 
930 nm and 970 nm. 











Tissue category 88.8 2 44.3762 17.77 2.06939e-08 
Wavelength 93.4 4 23.3564 9.35 1.59927e-07 
Tissue category*wavelength 90.6 8 11.3247 4.54 1.65093e-05 
Error 10038.1 4020 2.497   





Results of the two way ANOVA test shows that means of slope values are significantly different 
between different tissue types as the corresponding p value is small [2e-08] and slope means are 
also significantly different between different PA wavelengths [p value = 2e-7]. As the p value 
corresponding to interaction term is small [2e-5], the effects of wavelengths and tissue types 
depend on each other.  











Tissue category 67844.2 2 33922.1 317.05 1.39004e-128 
Wavelength 69552.6 4 17388.2 162.52 3.99605e-129 
Tissue category*wavelength  14296.6 8 1787.1 16.7 1.35037e-24 
Error   430105.9 4020 107   
Total     
598211.9  
4034    
 
Results of the two way ANOVA test shows that means of midband fit values are significantly 
different between different tissue types as the corresponding p value is very small [1e-128] and 
midband fit means are also significantly different between different PA wavelengths [p value = 
4e-129]. As the p value corresponding to interaction term is very small [1e-24], the effects of 















Tissue category 45866.6 2 22933.3 128.92 5.42326e-55 
Wavelength 78471 4 19617.8 110.28 2.59023e-89 
Tissue category*wavelength 10493.5 8 1311.7 7.37 8.75467e-10 
Error 715125.5 4020 177.9   
Total 598211.9 4034    
 
Results of the two way ANOVA test shows that means of intercept values are significantly 
different between different tissue types as the corresponding p value is very small [5e-55] and 
intercept means are also significantly different between different PA wavelengths [p value = 3e-
89]. As the p value corresponding to interaction term is very small [9e-10], the effects of 
wavelengths and tissue types depend on each other.  
Discussions: Focus of the simulation study was to evaluate the potential of power spectrum 
analysis of time dependent PA signal to differentiate between different tissue pathologies for our 
limited bandwidth PA acquisition system.   
Appropriate range of radius of the spherical PA absorbers: Depending upon the dimension of PA 
absorber, the corresponding PA spectrum can vary significantly while the detection bandwidth 




regression with PA spectrum. As the radius of the spherical PA absorber increases, more 
adjacent side lobes fall within the transducer bandwidth and that degrades the goodness of fit 
associated with linear regression. In this study, based on the goodness of fit of linear regression, 
an upper limit on radius [240 µm] of PA absorber for which the power spectrum analysis would 
be appropriate to apply, was determined. The lower limit on the radius of PA absorber was 
determined based on practical experience. From simulation, we observed that if the absorber 
radius was reduced below certain value then the corresponding slope of the best fit linear model 
became negative. When we applied power spectrum analysis to the PA signals generated by 
excised human prostate specimens, we did not observe negative slope value for any A-line PA 
signal. Based on that observation, we decided that the appropriate lower limit for our system [88 
µm] is the radius corresponding to the minimum positive slope.  
Relation between the spectral parameters and mean absorber radius: Xu et al. [5.13] established 
relations between dimension of the spherical absorbers and the spectral parameters for 
microspheres with identical sizes. For real biological tissue, the dimensions of the absorbers are 
expected to vary. In our study we investigated the relations using radii sampled from a given 
Gaussian distribution with a specific mean radius. This along with the introduction of noise 
similar to that present in our actual tissue PA data, made our simulation study close to the real 
tissue situation. Instead of finding out relation among spectral parameters with individual 
absorber radius values [5.13], we investigated relationship of different spectral parameters with 
mean absorber radii and our findings were identical with that of Xu et al. 
Resolving power of the power spectrum analysis: We investigated the minimum difference in 
radius between two absorbers that can still give rise to distinguishing parameters using PA power 




radius range, we chose mean radii separated by specific distances [40 µm, 30 µm, 20 µm and 10 
µm] and performed t test with the corresponding spectral parameters. We concluded that with 
our PA imaging system, it is possible to differentiate between two separate spherical absorbers 
using power spectrum analysis provided their radii are at least 30 µm apart. 
In the experimental study performed with prostate specimens, using marked histology slides of 
the prostate specimens as the ground truth, the spectral parameters corresponding to different 
tissue types, i.e. malignant, BPH and normal prostate tissue were analyzed. 
In statistical analysis, the two sample two tailed t test was performed for each spectral parameter 
at each of the five wavelengths. For ease of discussion, spectral parameters at different 
wavelengths are referred as different parameters. So, for each pair of different tissue types, two 
sample two tailed t tests were performed for fifteen parameters [three spectral parameters at five 
different wavelengths]. Results are presented for three pairs of tissue types; namely malignant vs. 
normal prostate, malignant vs. BPH and BPH vs. normal prostate. For the analysis, we assumed 
that when the p value was less than 0.05, the corresponding parameter would be significantly 
different for the chosen tissue pair. Under this criterion, in the case of malignant vs. normal 
prostate, thirteen out of fifteen parameters were significantly different. For malignant vs. BPH, 
twelve out of fifteen parameters were significantly different while for BPH vs. normal prostate, 
eleven out of fifteen parameters were significantly different. Since the primary focus of this 
study was to differentiate malignant prostate tissue from other types of prostate tissue, a separate 
tissue category called ―nonmalignant‖ prostate was created by combining all the normal as well 
as BPH ROIs and statistical analysis was performed to determine the capability of the spectral 
parameters for differentiating malignant ROIs from nonmalignant ROIs in prostate. In this case, 




also compared the performance of the three distinct spectral parameters [slope, midband fit and 
intercept] for all the wavelength and tissue pairs. Performance of midband fit was the best 
because for all the parameters the corresponding p values were well below the abovementioned 
significance criterion. Next was the intercept followed by the slope parameter. From the 
statistical analysis results, it is evident that frequency domain analysis is most effective in 
differentiating malignant prostate from normal prostate while it is least effective in 
differentiation BPH from normal prostate. When BPH and normal prostate ROIs were combined 
as nonmalignant, frequency domain analysis was very efficient in differentiating malignant from 
nonmalignant prostate. 
We can discuss our results from a theoretical standpoint. Using Equation 5.17, PA power 









































































































































































To compute the spectral parameters, right hand side of Equation 5.19 was fitted to a straight line 
and slope, intercept and midband fit were extracted from the straight line. It is evident that slope 




frequency and thus slope is independent of absorption coefficient µa of the absorber. Intercept is 
determined by the frequency independent terms i.e. log[µa] and log[r
2
]. Along with log[g(f)], 
Midband fit also depends upon log[µa] and log[r
2
]. As slope is independent of the absorption 
property and only depends upon the dimension of the absorber, it is generally regarded as the 
most useful one among the three parameters for providing information about the size of the 
absorber and consequently for differentiating between different tissue pathologies assuming 
absorber size changes with tissue pathology. According to Equation 5.15, the peak intensity of 
time dependent PA signal at any pixel location is generally considered to depend on absorption 
coefficient of the tissue but independent of the absorber diameter. Therefore the midband fit and 
intercept parameters may be regarded as superior to slope because of their combined dependence 
on both absorption coefficient and absorber diameter through the terms log[µa] and log[r
2
].  
Experimental PA data were acquired at five different wavelengths and the spectral parameters 
were extracted at all of these five wavelengths. According to the results of statistical analysis, 
considering the four pairs of different prostate tissue types, among the five wavelengths, 760 nm, 
800 nm and 850 nm are the three effective wavelengths at which the spectral parameters are 
better suited to differentiate between separate prostate tissue types than the other two 
wavelengths. As mentioned previously, the idea behind performing multiwavelength PA imaging 
was to exploit the wavelength dependent optical absorption property of the tissue for 
investigating the difference between different types of prostate tissue. Slope is expected not to 
change with wavelength as it is independent of wavelength dependent optical absorption 
property of the absorber. From Figure 5.18A and 5.19A, it can be seen that for all types of 
prostate tissue, change in corresponding mean slope value with the change of wavelength is 




intercept decrease with increasing wavelength. If we assume that deoxyhemoglobin is the 
primary chromophore present in the tissue specimens, then the decreasing specific absorption 
coefficient of deoxyhemoglobin with increasing wavelength in the 700 nm -1000 nm wavelength 
range explains the decreasing trend of mean midband fit and mean intercept with increasing 
wavelength. 
So, in conclusion, we can say that the simulation study demonstrates the capability of power 
spectrum analysis of PA signal for our limited bandwidth PA acquisition system whereas the 
results of experimental study establishes that the spectral parameters extracted from 3D PA data 
generated by freshly excised human prostates, can differentiate malignant prostate tissue from 
BPH as well as normal prostate tissue.  
5.2.5 Thyroid Specimens Results 
The mean values of the three spectral parameters corresponding to three different types of ROIs 
were plotted against the wavelengths in Figure 5.21. The mean values were computed over the 
respective number of ROIs that were included into the study corresponding to cancer, benign and 
normal thyroid tissue. At each point of all the plots, the error bar and the circle represent the 
standard deviation and median value of the corresponding parameter over the respective number 
of ROIs. The ROIs corresponding to benign and normal thyroid tissue were grouped into 
‗nonmalignant‘ category and the mean values of the three parameters corresponding to 





Figure 5.21: Plot of average values of the three parameters corresponding to different ROIs 
against five different wavelengths (A) Mean slope vs. wavelength (B) Mean midband fit vs. 
wavelength; (C) Mean intercept vs. wavelength. The error bar at each point is the standard 
deviation of the corresponding parameter over the respective number of ROIs. Circles represent 
median values of the parameters. 
 
Figure 5.22: Plot of average values of the three parameters corresponding to nonmalignant and 
malignant ROIs against five different wavelengths. (A) Mean slope vs. wavelength (B) Mean 
midband fit vs. wavelength; (C) Mean intercept vs. wavelength. The error bar at each point is the 
standard deviation of the corresponding parameter over the respective number of ROIs. Circles 




Two sample two tailed t-test was performed with the parameter values to find out whether there 
was statistically significant difference between the parameters corresponding to ROIs of different 
types. Figure 5.23 shows the results of the t-test performed at 5 % significant level with the 
values of three parameters corresponding to malignant vs. normal, malignant vs. benign, benign 
vs. normal and malignant vs. nonmalignant thyroid tissue. 
 
Figure 5.23: Comparison of spectral parameters between different thyroid tissue types (A) 
malignant vs. normal (B) malignant vs. benign (C) benign vs. normal (D) malignant vs. 
nonmalignant using two sample two tailed t-test. The red lines show the levels corresponding to 
decision criterion (p = 0.05). 
From Figure 5.23, it can be seen that between malignant and normal thyroid tissue, while 
midband fit and intercept are significantly different (p<0.05) for all the five wavelengths, besides 
at 800 nm, slope is not significantly different (p>0.05) for the other four wavelengths. Between 




besides at 760 nm, slope at all of the four other wavelengths are not significantly different 
(p>0.05). Between benign and normal thyroid all three spectral parameters at 970 nm and 
intercept at 760 nm and 970 nm are not significantly different (p>0.05). For malignant vs. 
nonmalignant thyroid slope values at five wavelengths are not significantly different while 
midband fit and intercept are significantly different (p<0.05).  
5.3 Spectral Centroid 
Spectral centroid a time dependent signal p(t) can be computed using Equation 5.20 
















                                                 5.20 
Here f represents frequency, S(f) is the Fourier transform of the time dependent signal p(t) and N 
is the total no of samples. 
Spectral centroids of the PA A-line signals corresponding to the identified ROIs in 3D PA data 
were computed using Equation 5.20. 
5.3.1 Prostate Specimen Results 
Two sample two tailed t-test was performed with the spectral centroid values extracted from the 
ROIs in 3D PA datasets to find out whether there was statistically significant difference between 
spectral centroid values corresponding to ROIs of different types. Figure 5.24 shows the results 
of the t-test performed at 5 % significant level with the values of the parameter corresponding to 
malignant vs. normal, malignant vs. BPH, BPH vs. normal and malignant vs. nonmalignant. The 






Figure 5.24: Comparison of spectral centroid between different prostate tissue types (A) 
malignant vs. normal (B) malignant vs. BPH (C) BPH vs. normal (D) malignant vs. 
nonmalignant using two sample two tailed t-test. The dashed lines show the levels corresponding 
to decision criterion (p = 0.05). 
From Figure 5.24, it can be seen that between malignant and normal prostate tissue, the spectral 
centroid values were significantly different (p<0.05) at all of the five wavelengths except 930 
nm. Between malignant and BPH prostate, besides 800 nm and 850 nm, spectral centroid values 
were significantly different (p<0.05) at the other wavelengths. For BPH vs. normal prostate, 
spectral centroid value was not significantly different (p>0.05) only at 800 nm. For malignant vs. 





Two way ANOVA test was performed with the spectral centroid values considering tissue 
category and wavelengths as two predictors. Tissue category contains three separate groups of 
tissue namely cancer, benign and normal, while wavelength consists of 760 nm, 800 nm, 850 nm, 
930 nm and 970 nm. 
Table 5.4: Two way ANOVA test results for spectral centroid values between different tissue 










Tissue category  61.86 2 30.9307 32.23 1.3023e-14 
Wavelength 210.69 4 52.6724 54.88 4.05942e-45 
Tissue 
category*chromophore 
51.27 8 6.4083 6.68 1.0296e-08 
Error   3858.22 4020 0.9598   
Total  4242.04 4034    
 
Results of the two way ANOVA test shows that means of spectral centroid values are 
significantly different between different tissue types as the corresponding p value is very small 
[1e-14] and spectral centroid means are also significantly different between different PA 
wavelengths [p value = 4e-45]. As the p value corresponding to interaction term is very small 





5.3.2 Thyroid Specimen Results 
Two sample two tailed t-test was performed with the spectral centroid values extracted from the 
PA ROIs corresponding to different types of thyroid tissue to find out whether there was 
statistically significant difference between spectral centroid values corresponding to different 
thyroid tissue types. Figure 5.25 shows the results of the t-test performed at 5 % significant level 
with the values of the parameter corresponding to malignant vs. normal, malignant vs. benign, 
benign vs. normal and malignant vs. nonmalignant thyroid tissue. The ROIs corresponding to 
benign and normal thyroid tissue are grouped into the ‗nonmalignant‘ category. 
 
Figure 5.25: Comparison of spectral centroid between different thyroid tissue types (A) 
malignant vs. normal (B) malignant vs. benign (C) benign vs. normal (D) malignant vs. 
nonmalignant using two sample two tailed t-test. The dashed lines show the levels corresponding 




From Figure 5.25, it can be seen that between malignant and normal thyroid tissue, the spectral 
centroid values are significantly different (p<0.05) at all of the five different wavelengths. 
Between malignant and benign thyroid, besides 760 nm, spectral centroid values are significantly 
different (p<0.05) at the other wavelengths. For benign vs. normal thyroid, spectral centroid 
value is not significantly different (p>0.05) only at 970 nm. For malignant vs. nonmalignant 

















CHPATER 6: Computer Aided Diagnosis Using Extracted PA Features 
6.1 Computer Aided Diagnosis (CAD) 
Conventional decision making method for prostate cancer diagnosis and management involves 
basic analysis of a combination of a few markers by a radiologist. Radiologists, being human 
beings, cannot process and analyze large number of markers for making the decision which may, 
sometime produce inferior decisions. On the other hand, computer based decision making 
models or classifiers like artificial neural network (ANN) or support vector machine (SVM) can 
perform multivariate analysis and model nonlinear relationships between inputs and outputs. 
CAD is gradually becoming popular for prostate cancer detection, staging and management.  
In Chapter 4 & Chapter 5, several features were extracted from the multiwavelength 3D PA data 
of excised prostate specimens and statistical analysis were performed to test whether the 
extracted features were significantly different between different tissue pathologies. The next step 
would be to test the capability of the extracted features to identify or predict a particular tissue 
pathology using a suitable classifier model. 
6.2 Literature Review of CAD of Prostate cancer 
Lee et al. compared the performances of decision models based on logistic regression, SVM and 
ANN classifiers for predicting outcome of prostate biopsy of actual human patients using input 
data consisting of age, DRE findings, PSA information and TRUS findings and for their study, 
performance of SVM was best among the three classifiers [6.1].  Using tumor stage, PSA 
information, Gleason score and age as input variables, Botoca et al. observed that ANN 
performed better that logistic regression to predict prostatic capsule penetration for their study 




applied an ANN model to predict skeletal matastasis in patients with prostate cancer [6.3]. 
Saritas et al. devised an ANN model to predict whether a patient has prostate cancer or not using 
free PSA, total PSA and age information and the outcome of the model can eventually help the 
doctor to take the decision whether or not to conduct the biopsy [6.4]. Cinar et al. implemented 
SVM and ANN classifiers for early diagnosis of prostate cancer using prostate volume, PSA, 
density and age information as input variables [6.5].  Kawakami et al. have compared the 
performances of logistic regression based models with that of ANN based models for predicting 
prostate cancers in patients using age, DRE information, PSA information, prostate volume and 
TRUS findings [6.6]. Using clinical TNM classifications, Gleason scores, PSA information, 
TRUS findings and MRI findings as input variables, Polakis et al. compared the performances of 
the ANN based models and regression based models for predicting biochemical recurrence after 
radical prostatectomy [6.7]. Using SVM classifiers, Moradi et al. compared the performances of 
different types of features extracted from RF US time series data for predicting prostate cancer in 
an ex-vivo study [6.8]. Using ANN classifier trained by features extracted from RF US signal 
and PSA information, Fellepa et al. computed cancer likelihood score at each pixel and generated 
greyscale images displaying scores at each pixels [6.9]. Alqasemi et al. compared the 
performances of generalized regression model, SVM and ANN to predict ovarian cancer using 
features extracted from coregistered UA and PA images of ex vivo ovarian specimens [6.10]. 
6.3 Building Multidimensional Feature Space 
Multiwavelength 3D PA images of 30 excised prostate specimens were acquired at our 
laboratory. Using marked histology images as ground truth, ROIs corresponding to malignant, 
benign and normal prostate tissue were identified in the 3D PA images. Each ROI contains 




tissue. We assumed each PA A-line signal contains characteristics of the particular tissue type to 
which it belongs and so rather than extracting features from individual ROIs, we extracted 
features from individual PA A-line signals. Total number of input feature vectors is 807 among 
which 398 vectors belong to malignant prostate while the rest belong to nonmalignant prostate 
[normal - 276, BPH - 133]. Since the primary objective of this study was to detect malignant 
prostate tissue, here only two classes namely malignant and nonmalignant were considered. 
The extracted features from 3D PA images can be divided into three different categories 
representing different optical and physiological properties of the tissue specimens. The three 
categories are; 
A. PA pixel values [Grayscale pixel values of 2D C scan PA images formed from acquired 3D 
PA data] - 5. 
B. Chromophore concentrations [Spatially varying concentrations of four different 
chromophores, computed using the multiwavelength PA pixel values]. 
C. Frequency parameters [Slope, midband fit and intercept values and spectral centroid of each 
PA A-line at five different wavelengths] – 20. 
Combining all the features together, a 29 dimensional input feature space was built.  
6.4 ANN 
The aim of the classification algorithms is to assign an input vector x to one of the K distinct and 
disjoint classes. In supervised classification, a large dataset is used to train the parameters of an 
adaptive model or classifier exploiting the prior knowledge of each of the input vector‘s 




known as testing dataset, is used to test the ability of the classifier to correctly categorize input 
data which does not have any overlap with training dataset. An appropriate function y(x) can be 
formed to represent the classifier or the adaptive model. The value of y(x) corresponding to the 
input vector x represents the value of the target variable t. For two class problem, t can be a 
scalar variable which can be used to represent either of the class labels. For more than two class 
problem, t has to be a vector variable whose number of elements is equal to the number of 
classes and each element is designated to represent a specific class label.  
A simple generalized linear model used for a two class problem can be expressed as  
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Where x = (x1, x2, …… xN)
T
 is the input vector in the N dimensional input space, w = (w1, w2, 
……..wN)
T
 is the parameter vector, w0 is the bias parameter and f(.) is the nonlinear activation 
function used specially for the classification purpose. To make the model more generalized, x 
can be replaced by a fixed nonlinear function υ(x) known as basis function of x. Then Equation 
6.1 can be written as 
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Here υ = (υ1,……υM)
T
 and υ0(x) = 1. 
Artificial Neural Network (ANN) is a computer generated information processing system which 
is motivated by the function of biological nervous systems such as animal brain. An ANN has a 




network of units can work together in a distributive manner to learn from input information and 
discover new information.  
The most commonly used ANN has three layers, namely input, hidden and output. Each layer 
contains a number of nodes or neurons which are interconnected by links. Each link has its own 
weight over which the signal is transferred from one node to another. Every node receives 
information from a number of other nodes and produce output that depends on the combination 
of received information.  
An ANN uses basis functions each of which is a nonlinear function of the linear combination of 
the components of input vector. As the basis functions depend upon the parameters used for 
combining the input vector components, these parameters as well as the parameter vectors w in 
Equation 6.2 are adjusted during training. So, the most commonly used ANN model can be 
represented by the following equation. 

























kjkk wwxwhwwxy                                          6.3  
Here yk represents the value of the model at kth output and σk is the activation function at the kth 
output node. 
Now, to obtain Equation 6.3, each layer has to be considered sequentially i.e. starting from the 
input layer we need to move forward until output layer is reached. Here, we have only 
considered feed-forward architecture where the information progresses in the forward direction 
via the network. If we consider N dimensional input space, then the input layer will contain N 
nodes. Linear combination of the input variables, applied at the input nodes can be represented 












                                                           6.4  
Here the subscript j represents a particular node (jth) in the hidden layer and the wji is the weight 
corresponding to the link which connects jth node in the hidden layer to ith node in the input layer. 
The bias parameter connected to the jth node in the hidden layer is wj0 while ahj is the linear 
combination of the nodes in input layer. Now if hj is considered to be the nonlinear activation 
function for the jth node, then 
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Where zj is the ouput of the jth hidden node. Now if the hidden layer is M dimensional i.e. if it 
contains M nodes in total, then the linear combination of the outputs of all the hidden nodes at kth 
node in the output layer can be expressed as 








                                                           6.6  
Now if the activation function for each output node is σ, then  
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Combining Equation 6.4, 6.5, 6.6 & 6.7 we obtain Equation 6.3. 
During training, using the input training vectors and the corresponding target variables, the set of 
parameter vectors or weights associated with different links in the ANN are adjusted to minimize 
a particular error function. The type of error function is chosen depending upon the particular 





















                                              6.8 
Here tkn represents the value of the target variable at kth output node for input xn and yk 
represents the model output at kth output node for xn. The particular set of w parameters or the 
weight vectors which yields the minimum E, is determined during training of ANN. Now the 
minimum points of the error function can be located efficiently by computing the gradient of the 
error function ∇E, as ∇E points the direction of greatest increase of error.  
The gradient of error function is computed by using a method known as error backpropagation in 
which information is sent forward and backward alternately through the ANN. Generally, during 
training of ANN, minimization of the error function is achieved via an iterative process using a 
sequence of steps. Each such step can be divided into two separate stages. In stage one, 
derivatives of the error function [gradient, jacobian or heissian of the error function] with respect 
to weights are computed using backpropagation algorithm. Then in the next stage the computed 
derivatives are used by a suitable optimization scheme to adjust or update the weight vectors 
until the minimum error points are reached. In batch methods, the complete dataset is used at 
once whereas the online methods adjust weight vector using one data point at a time [6.11].   
Application of ANN on the actual data 
The ANN used in this study, was built and executed using MATLAB Neural Network toolbox. 
Here a feed forward ANN was used. The ANN had one input layer, one hidden layer and one 
output layer. Number of nodes in the input layer was equal to the dimension of the input feature 
space [29 for the combination of all extracted features] while hidden layer and the output layer 




dataset [807 x 29] was scaled in the range of -1 to 1 using the ‗mapminmax‘ function available in 
the NN toolbox. The ‗mapminmax‘ function uses the Equation 6.9 to scale the data 
















xscale                                                       6.9 
The whole dataset was divided into training set and testing set such that the ratio of train strength 
[number of training set members]: test strength [number of testing set members] was 60:40. The 
assignment of data members to training and testing data sets was completely random. The ANN 
was trained with the training set using ‗trainlm‘ function in the NN toolbox. The ‗trainlm‘ 
function calculates the jacobian of the performance/error metric with respect to weight and bias 
vectors at each step and then implements Levenberg-Marquardt optimization to adjust the weight 
and bias vectors. The network architecture was trained with the training data for 10 times. For 
each session, the training started with different sets of initial values of weights and biases. In 
each session, after training was complete, the performance of the network was tested with the 
testing dataset by measuring the MSE using Equation 6.8. The trained network which yielded the 
best performance i.e. the lowest MSE for the testing set, was selected as the optimum network 
and the corresponding classification results were saved. The complete process [starting from the 
random division of training and testing datasets] was performed 50 times to be certain about the 
network performance. The mean, median and standard deviation of sensitivity and specificity 
obtained with training and testing data set have been reported in results. The transfer function 
used in the hidden layer was ‗tansig‘ and in the output layer ‗softmax‘. Equation 6.10 and 6.11 
describe the ‗tansig‘ and ‗softmax‘ algorithms.
                                                                                                



















                                                    6.11 
After the ANN was used to classify the malignant and nonmalignant prostate tissue using the 
complete feature space, similar network architechture [same number of layers and nodes] was 
employed to determine which category of the features were most efficient in predicting prostate 
cancer. Input data consisting of only multiwavelength PA pixels [5 dimensional feature space], 
spatially varying chromophore concentrations [4 dimensional feature space] frequency 
parameters [20 dimensional feature space] and a combination of PA pixels and chromophore 
concentrations [9 dimensional feature space] were used to train and test ANN classifiers in the 
exact same manner as described earlier.  
6.5 SVM: 
The linear discriminant function for the two class classification problem can be expressed as 
                                                        0
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Where y is the output of the model, x is the input vector, w and w0 are the weight vector and the 
bias and υ(x) is the basis function. Let the training data [considering supervised classification] 
comprises of N input vectors with corresponding target values represented by tn [tn can only be 0 
or 1]. If we assume that the training data are linearly separable in the basis function space, then w 
and w0 can be evaluated using training dataset. Any new input vector will be correctly classified 
if its corresponding target variable tn =1 and the model output y(x)>0, or if tn = 0 and y(x)<0 
where y(x) = 0,represents the decision boundary in basis space. 
A support vector machine (SVM) selects the decision boundary corresponding to maximum 




data point and the decision boundary. The perpendicular distance between a data point xn and the 
decision boundary is 








                                                         6.13  
As for correctly classified data points tny>0, so the expression for margin can be written as 
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The parameters w and w0 need to be optimized to find out the maximum margin solution. The 
maximum margin optimization problem can be written as 






















                                                6.15  
With proper scaling, for a correctly classified training data point xn which is also the nearest data 
point to the decision boundary, Equation 6.16 can be written. 
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As maximizing 1/||w|| is equivalent to minimizing ||w||
2
, so considering all of the correctly 
classified training data points, the optimization problem can be rewritten as following 








  subjected to the constraints   1)( 0 wxwt nTn                          6.17                        
The Lagrange function for the optimization problem can be written as 
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Where a = (a1,a2,……..an)
T





Differentiating Equation 6.18 with respect to w, w0 and equating the results with zero, Equations 
6.19 and 6.20 are obtained. 
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                                                                 6.20 
Combining Equation 6.18, 6.19 and 6.20, the optimization problem can be converted into the 
following dual representation problem where Ld is maximized. 
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The above maximization problem is solved to find out the Lagrange multipliers a = (a1, 
a2…………an)
T
 during training.         
After training, any new data point or member of the testing set is classified according to the sign 
of y(x) in Equation 6.23. 
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As a constrained optimization problem satisfies Karush-Kuhn-Tucker conditions [6.11], so 
0na  
  01nn xyt  
                                                            




So, for every data point in the training set either an = 0 or tny(xn) = 1. Now the points for which 
an = 0, do not contribute anything to Equation 6.24. So, the contributing data points are those for 
which tny(xn)  = 1. As these points lie on the maximum margin hyperplane, they are known as 
support vectors.  Once the support vectors and the Lagrange multipliers are found, the bias 
parameter w0 can be computed using Equation 6.25. 

















0                                                6.25 
The above Equations have been derived based on the assumption that the training dataset is 
linearly separable in the basis function space. Similar Equations can also be derived for 
overlapping class conditional distribution which is more practical [6.11] . 
Application of SVM to the prostate PA data: 
For building and executing SVM classifiers, a python based machine learning toolkit named 
‗scikit-learn‘ was used [6.12]. As mentioned earlier for the ANN classifier, the number of input 
vectors was 807 while the dimension of the feature space was 29. The complete input dataset 
was scaled in the range 0 to 1. Using 60% of the dataset a training set was formed and the rest 
was used to form the testing set. The assignment of feature vectors to training and testing sets 
was completely random. We worked with polynomial and Gaussian radial basis function [RBF] 
kernel types to select the kernel with best performance. We performed exhaustive searches in the 
parameter space to find out the appropriate values of the hyperparameters [C and γ for RBF, C 
for polynomial of order 3] as well as the appropriate type of kernel function. For each set of 
parameter and each kernel type, fivefold cross validation was performed. RBF kernel with C = 
100 and γ = 1.5 yielded the best performance for classifying malignant and nonmalignant 





6.6 Results & Discussions 
Classification Metrics 
Confusion matrix: It tabulates the performance of a supervised learning classifier in a matrix 
form where each row represents the instances of actual classes and each column represents the 
instances of predicted classes. 














True Positive [TP] 
 




False Positive [FP] 
 
True Negative [TN] 
 
Table 6.1 shows the example of the confusion matrix which tabulates the performance of a 
classifier predicting malignant and nonmalignant tumors. For a given classifier and an instance 
(input feature vector), there can be four possible outcomes. If the instance actually belongs to 
malignant category and the classifier also predicts it as malignant, then it will be counted as 
‗True Positive (TP)‘. Similarly if the instance is nonmalignant and the prediction by the classifier 
is also nonmalignant, then it will be counted as ‗True Negative (TN)‘. On the other hand if the 




that will be marked as ‗False Negative (FN)‘. Similarly, if the instance is nonmalignant and the 
classifier labels it as malignant then that will be marked as ‗False Positive (FP)‘. Using the 
number of TP, TN, FP and FN, following classification metrics can be computed. 
Sensitivity or Hit rate or Recall or True Positive Rate (TPR) = TP/ [TP + FN]. 
Specificity = TN/ [FP + TN]. 
Precision or Positive Predictive value [PPV] = TP/ [TP + FP]. 
Negative Predictive value [NPV] = TN/ [TN + FN]. 
False Positive Rate [FPR] = 1- Specificity = FP/ [FP + TN]. 
For our data, malignant represents positive class and nonmalignant represents negative class. 
Receiver Operating Characteristics (ROC) curve: A ROC graph is obtained by plotting 
sensitivity or TPR vs FPR or 1-specificity for different values of threshold. It shows the relative 
tradeoff between profit i.e. TP and cost i.e. FP. The point (0, 1) represents perfect classification. 
The point (0, 0) corresponds to zero false positives and zero true positive while the point (1, 1) 
represents unconditional positive classification. The diagonal line with unit slope in the ROC 
graph represents the results of random guessing [6.13]. For example, if a classifier guesses 
randomly positive outcome 80% of the time then one can expect it to predict 80% of the 
positives correctly, but at the same time the false positive rate will also increase to 0.8 and thus 
the corresponding point in the ROC space will be (0.8, 0.8).  
Area under Receiver Operating Characteristics curve (AUROC):  The Area under ROC graph 




outcome higher than the randomly chosen negative outcome [6.13]. This metric is generally used 
to compare the performance of different classifiers used for the same purpose. 
SVM Classifier Results: 
Input dataset: 807 x 29 
Train data: Test data = 60:40. 
Kernel used: RBF [C = 100, γ = 1.5]. 
Table: 6.2 Classification Results with SVM on the complete dataset 
 Training data Testing Data 
Sensitivity 0.98 0.84 
Specificity 0.98 0.91 
Precision 0.98 0.90 
NPV 0.98 0.86 






Figure 6.1: ROC for SVM Classifier with test data. 
Figure 6.1 shows the ROC graph for the SVM classifier applied to our dataset for detecting 
prostate cancer. The AUROC is 0.96. 
ANN Classifier Results:  
A. Using the complete 29 dimensional feature space. 
Input dataset: 807 x 29  






Table 6.3: Classification Results with ANN on the complete dataset. Here Mean, Std. dev 
[standard deviation] and Min [minimum] are the mean, standard deviation and minimum of the 
results obtained in 50 iterations. 
 Training data Testing Data 
Sensitivity Mean = 0.97, Std. dev = 0.014, Min = 
0.92  
Mean = 0.93, Std. dev = 0.02, Min = 
0.88 
Specificity Mean = 0.96, Std. dev = 0.02, Min = 
0.89 
Mean = 0.91, Std. dev = 0.03, Min = 
0.86 
Precision Mean = 0.96 Mean = 0.92 
NPV Mean = 0.97 Mean = 0.93 






Figure 6.2: ROC for ANN Classifier with test data [29 dimensional] 
Figure 6.2 shows the ROC graph for the ANN classifier applied to our dataset [29 dimensional] 
for detecting prostate cancer. The AUROC is 0.99. For plotting the ROC curve, we selected the 
best results i.e. which correspond to highest accuracy out of 50 iterations. 
Comparing the performance of ANN and SVM for predicting malignant prostate tissue using 29 
dimensional input data, it can be concluded that ANN performed better that SVM as the AUROC 
for cancer detection in case of ANN is higher [0.99] than that of SVM [0.96]. Also both of 
sensitivity and accuracy of ANN with test data [0.93 and 0.91] are higher than those of SVM 






B. Using only the multiwavelength PA pixel values. 
Input dataset: 807 x 5 
Train data: Test data = 60:40. 
Table 6.4: Classification Results with ANN on the subset containing only the multiwavelength 
PA pixels. Here Mean, Std. dev [standard deviation] and Min [minimum] are the mean, standard 
deviation and minimum of the results obtained in 50 iterations. 
 Training data Testing Data 
Sensitivity Mean = 0.81, Std. dev = 0.05, Min = 
0.67  
Mean = 0.78, Std. dev = 0.05, Min = 
0.66 
Specificity Mean = 0.67, Std. dev = 0.07, Min = 
0.53 
Mean = 0.63, Std. dev = 0.06, Min = 
0.53 
Precision Mean = 0.72 Mean = 0.69 
NPV Mean = 0.77 Mean = 0.74 






Figure 6.3: ROC for ANN Classifier with test data [5 dimensional] 
Figure 6.3 shows the ROC graph for the ANN classifier applied to a subset of data containing 
only multiwavelength PA pixel values [5 dimensional] for detecting prostate cancer. The 
AUROC is 0.85. For plotting the ROC curve, we selected the best results i.e. which correspond 









C. Using only the chromophore concentrations. 
Input dataset: 807 x 4 
Train data: Test data = 60:40. 
Table 6.5: Classification Results with ANN on the subset containing only the chromophore 
concentrations. Here Mean, Std. dev [standard deviation] and Min [minimum] are the mean, 
standard deviation and minimum of the results obtained in 50 iterations. 
 Training data Testing Data 
Sensitivity Mean = 0.87, Std. dev = 0.02, Min = 
0.81  
Mean = 0.85, Std. dev = 0.03, Min = 
0.76 
Specificity Mean = 0.79, Std. dev = 0.03, Min = 
0.71 
Mean = 0.77, Std. dev = 0.03, Min = 
0.70 
Precision Mean = 0.81 Mean = 0.79 
NPV Mean = 0.86 Mean = 0.83 






Figure 6.4: ROC for ANN Classifier with test data [4 dimensional] 
Figure 6.4 shows the ROC graph for the ANN classifier applied to a subset of data containing 
only chromophore concentration values [4 dimensional] for detecting prostate cancer. The 
AUROC is 0.91. For plotting the ROC curve, we selected the best results i.e. which correspond 









D. Using only the frequency parameters [slope, midband fit, intercept extracted from power 
spectrum analysis and spectral centroid. All were extracted for five different wavelengths]. 
Input dataset: 807 x 20 
Train data: Test data = 60:40. 
Table 6.6: Classification Results with ANN on the subset containing only the frequency 
parameters. Here Mean, Std. dev [standard deviation] and Min [minimum] are the mean, 
standard deviation and minimum of the results obtained in 50 iterations. 
 Training data Testing Data 
Sensitivity Mean = 0.91, Std. dev = 0.03, Min = 
0.79  
Mean = 0.85, Std. dev = 0.03, Min = 
0.79 
Specificity Mean = 0.90, Std. dev = 0.04, Min = 
0.77 
Mean = 0.84, Std. dev = 0.04, Min = 
0.71 
Precision Mean = 0.90 Mean = 0.84 
NPV Mean = 0.90 Mean = 0.84 






Figure 6.5: ROC for ANN Classifier with test data [20 dimensional] 
Figure 6.5 shows the ROC graph for the ANN classifier applied to a subset of data containing 
only frequency parameter values [20 dimensional] for detecting prostate cancer. The AUROC is 
0.96. For plotting the ROC curve, we selected the best results i.e. which correspond to highest 










E. Using the combination of multiwavelength PA pixels and chromophore concentration values. 
Input dataset: 807 x 9 
Train data: Test data = 60:40. 
Table 6.7: Classification Results with ANN on the subset containing the multiwavelength PA 
pixel values and chromophore concentrations. Here Mean, Std. dev [standard deviation] and Min 
[minimum] are the mean, standard deviation and minimum of the results obtained in 50 
iterations. 
 Training data Testing Data 
Sensitivity Mean = 0.93, Std. dev = 0.02, Min = 
0.87  
Mean = 0.90, Std. dev = 0.03, Min = 
0.83 
Specificity Mean = 0.84, Std. dev = 0.05, Min = 
0.74 
Mean = 0.80, Std. dev = 0.04, Min = 
0.72 
Precision Mean = 0.85 Mean = 0.82 
NPV Mean = 0.92 Mean = 0.89 






Figure 6.6: ROC for ANN Classifier with test data [9 dimensional] 
Figure 6.6 shows the ROC graph for the ANN classifier applied to a subset of data containing 
multiwavelength PA pixel values and chromophore concentrations [9 dimensional] for detecting 
prostate cancer. The AUROC is 0.96. For plotting the ROC curve, we selected the best results 
i.e. which correspond to highest accuracy out of 50 iterations. 
Comparing the performances of the ANN classifier using features of different categories, it can 
be concluded that Frequency parameters performed best for detecting malignant prostate tissue 
as the corresponding AUROC is the highest. Its performance is similar to the performance of the 
combination of PA pixels and chromophore concentrations. 
Generally researchers concentrate on recovering chromophore concentration from the PA images 
as chromophore concentration provide direct physiological information about the tissue which 




parameters also can be used with significant efficiency for identifying tissue abnormality. 
Although, the frequency parameters do not provide any functional information about the tissue 
directly like chromophore concentration, but since midband fit and intercept parameter depend 
partially on the amount of light absorbed by the tissue, so there may exist some indirect 
nonlinear relationship between multiwavelength midband fit and intercept parameters with 
chromophore concentration. We established in Chapter 5 that midband fit and intercept depend 
both on optical properties and dimension of PA absorber. Since slope depends on the absorber 
size only while the other two parameters depend on both size and optical property of tissue, so a 
combination of these three parameters at multiple wavelengths may really be useful for tissue 














CHAPTER 7: Novel Ultrasound Imaging System 
7.1 Dual Mode PA and US Imaging System 
As mentioned earlier, PA signals map optical absorption property of the tissue. Either the 
grayscale [B scan or C scan] PA images or different parametric images [e.g. chromophore 
concentration, frequency parameters] formed using the PA signals, can be used to detect 
particular tissue pathologies. But, the grayscale or parametric images do not bear any structural 
information of the tissue or in other words they cannot localize the particular tissue pathologies 
they are detecting. For diagnosis and treatment of cancer, localization of the cancer lesions is 
very important. For example, while performing needle biopsy to diagnose prostate cancer, if the 
detected lesion can be localized clearly, then direct sampling can be performed rather than 
sampling the complete gland and that will reduce diagnosis uncertainty and physical discomfort 
of the patient. As the bulk modulus variation based contrast is small in soft tissue, US imaging 
has low accuracy in detecting cancer lesions. But it can reveal structural information like 
boundary of a complete organ or presence of other nearby organs. For prostate, TRUS can depict 
the important anatomical structures like urethra, bladder, prostate capsule etc. which can be used 
as important cues to localize a detected cancer lesion during needle biopsy. So, if coregistered 
PA and US image of the same organ can be fused together, then the fused image can potentially 
detect and localize particular tissue pathology with high accuracy. For prostate cancer diagnosis, 
a dual mode TRUS and PA imaging probe will be of critical significance as it can potentially 
reduce the number of sample cores significantly, encourage targeted biopsy and also play a 
critical role in monitoring the status of the tumor after treatment. Since both US and PA imaging 




same which makes it possible to produce coregistered PA and US images without the help of any 
fiduciary markers.  
7.1.1 Literature Review 
Several research groups have built dual mode PA and US imaging systems. The dual mode 
imaging systems have been built either by suitable modification of the existing commercially 
available diagnostic ultrasound scanners [7.1 – 7.4] or using the same US transducer system 
[single element transducer or transducer array] both for PA and US imaging along with the laser 
source and suitable electronics in the laboratory setup [7.5 – 7.7].  
In this study, we developed a novel pulse echo US imaging system which can be easily 
integrated with our existing ex-vivo PA imaging system to produce the dual mode imaging 
system. In the US imaging system, two different ultrasound transducer assemblies were used to 
transmit and receive the US wave. A Polyvinylidene fluoride (PVDF) film transducer was used 
as the source transducer. The PVDF transducer generates plane US wave. The US wave are 
backscattered by the object and the backscattered wave get focused by a spherical acoustic lens 
on to a linear array of transducers. To improve the anticipated low SNR of the received US 
signal due to the low electromechanical coupling coefficient of the PVDF film, we implemented 
pulse compression technique using linear frequency modulated (FM) signals or chirp signals. 
7.2 Acoustics Lens Based Focusing 
To improve the lateral resolution of the US B-scan images, various focusing technologies can be 
implemented. Focusing with single element transducer can be achieved by spherically curving 
the transducer or attaching an acoustic lens with the single element transducer [7.8].  A phased 




the excitation signals for different elements and can receive focused backscattered signal by 
applying appropriate time delays to the elements during receiving. Although focusing at variable 
depths can be achieved with the phased array transducer, it requires expensive dedicated 
electronics [7.8, 7.9]. Also, for this process, each point in a certain cross-sectional object plane 
has to be scanned separately. In this study, an acoustic lens focusing based imaging system is 
explored. In this imaging system, focusing can be achieved by the acoustic lens and thus the 
single element acoustic lens replaces the expensive and dedicated electronics that has to be used 
if we employed phased arrays. To ensure that US plane wave was incident on the object, two 
separate transducers were used here as source and receiver of the US wave. The acoustic lens 
was placed in between the object and image plane in such a way that it was separated from both 
the object and image plane by a certain distance. In this configuration, all points at a particular 
cross-sectional object plane can be imaged at the same time at the corresponding image plane.  
7.3 PVDF film as US Generator 
A PVDF film transducer was used here as the plane wave generator. PVDF is a semicrystalline 
polymer material with strong piezoelectric property [7.10]. Due to its wide bandwidth, low 
acoustic impedance and high flexibility it is suitable for high frequency tissue imaging [7.11, 
7.12]. Although it is not an ideal US transmitter due to its low electromechanical coupling 
coefficient, it has very high receiving sensitivity [7.12, 7.13]. In this imaging system, the beam 
axis of the source and receiver US transducers are on the same line and as it can be seen in 
Figure 7.1, the backscattered US wave has to pass through the US source. The presence of the 
source in the way of the backscattered US wave produces insertion loss. The acoustic impedance 
of a PVDF film is an order of magnitude nearer to that of water than the acoustic impedance of a 




impedance mismatch between PVDF film and water is much lower than the impedance 
mismatch between conventional ceramic transducer materials and water. This low impedance 
mismatch reduces the insertion loss produced by the PVDF film compared to the insertion loss 
that would be produced if PZT transducer was used. In addition to this, the lower thickness of the 
PVDF film compared to a conventional ceramic transducer reduces the wavefront distortion of 
the backscattered US wave [7.13].  
7.4 Pulse Compression 
As mentioned earlier, PVDF is not a good US transmitter. The electromechanical coupling 
efficiency of PVDF is approximately three times lower than that of a PZT transducer [7.11, 
7.13]. It was anticipated that, due to the low electromechanical coupling coefficient of PVDF 
film, the amplitude of the input US plane wave might be low even after amplification. This low 
amplitude input plane US wave would produce US images with low SNR. To improve the SNR 
of the backscattered US wave, pulse compression technique using linear frequency modulated 
signal was implemented here. Pulse compression using frequency modulated signal is a well 
established technology. In conventional medical ultrasound imaging systems, it is used to 
increase penetration depth and improve SNR deep inside the tissue [7.14 – 7.16]. The axial 
resolution of an US imaging system improves with increasing frequency of the input US signal. 
But at the same time, due to the frequency dependent attenuation property of the tissue, the 
corresponding SNR degrades with increasing depth inside the tissue which in turn reduces the 
penetration depth. Improving the SNR by increasing the peak intensity of the input signal is not a 
solution as the peak intensity has to stay within the safety limit [7.14, 7.15]. Instead of using a 
short pulse as in conventional pulse echo system, the pulse compression technique uses a long 




duration input signal which reduces the peak intensity. After receiving, the backscattered signal 
is fed to a matched filter which adjusts relative phases of the frequency components to produce 
the compressed pulse with improved SNR [7.14, 7.15]. The time duration of the compressed 
pulse is comparable to that of a conventional short pulse and thereby the axial resolution is 
maintained.  
Let us assume P(t) is the input FM wave and the backscattered wave S(t), is equal to sum of the 
shifted and scaled replica of P(t) and uncorrelated noise n(t).  
                                                        )()()( tntPtS                                                          7.1  
Where α is the scale factor and τ is the time shift of P(t). Now if S(t) is applied to a matched filter 
with impulse response P*(-t) where P*(t) is the complex conjugate of P(t), then the compressed 
pulse will be given by                        
       )()()()()()(*)()(*)()()( tPtntPtPttPtntPtPtPtS 
            7.2 
Equation 7.2 tells us that the compressed pulse will be a scaled replica of the autocorrelation 
function of P(t) at the shifted time coordinate τ [7.17]. Ideally, the noise n(t) is expected to be 
uncorrelated to P(t), resulting 0)()(  tntP . The  symbol represents correlation operation 
whereas the  symbol represents convolution operation. A typical linear FM signal or chirp 
signal can be expressed by Equation 7.3 






tBftP c      For 0< t < T0                                      7.3 
Here T0 is the time duration, 2B/ T0 is the linear frequency sweep rate and fc is the center 
frequency of the chirp signal. The sweep bandwidth 2B of the chirp signal extends from (fc – B) 
to (fc + B). Autocorrelation of P(t) results in a signal which is amplitude modulated by a sinc 




sweep bandwidth 2B, also known as the time bandwidth product [7.18]. Ideally, the 
improvement of SNR after pulse compression is equal to the time bandwidth product of the input 
FM signal [7.16]. It can also been shown that if the bandwidths of the input signals for 
conventional short pulse and the linear FM signal are equal, then the axial resolution obtained for 
both the cases are more or less equal [7.18].     
The primary purpose of this work was to explore the feasibility of the novel acoustic lens 
focusing based US imaging system and the use of a PVDF film transducer as US transmitter. The 
PVDF film transducer was used here as the US plane wave generator to satisfy the requirement 
of a US plane wave source so that echoes from all points in a given a depth plane, after being 
focused by the acoustic lens, arrive at the US receiver almost at the same time. The secondary 
purpose of this work was to explore the feasibility of implementing of pulse compression 
technique in the above mentioned imaging system. The pulse compression technique is a well-
established technique for SNR enhancement and it has been applied successfully to improve 
SNR for several US medical imaging systems [7.14 – 7.16, 7.18]. In the proposed imaging 
system, an acoustic lens was used as the focusing element. We suspected that the spherical 
curvature of the lens might distort the quadratic phase modulation of the input chirp signal and 
subsequently pulse compression might fail. So we wanted to test whether the pulse compression 
technique could be implemented in presence of the acoustic lens. In the conventional pulse echo 
system, the same transducer is used as the source and the receiver. So for that, the input pulse 
duration must be less than the time taken by US wave to travel back and forth between the source 
and the detector. No such constraint is there for our setup, as two different transducer assemblies 
are used here as source and receiver. So for this set up, an input chirp pulse longer than usual can 




input chirp. As this US system uses the same acoustic lens based focusing technology and a 
similar linear transducer array used in our existing ex vivo PA imaging system, so it can be 
easily integrated to our existing PA imaging system with minor modifications to acquire 
coregistered PA and US images of the tissue sample. 
7.5 Experimental Setup 
Figure 7.1 describes the framework of the experiments performed in a water tank [7.19]. 
 
 
Figure 7.1: Experimental setup 
In the above setup, the PVDF film transducer (Measurement Specialties: FDT1-028K 28μm 
thick/ NDT1-220K 220μm thick) emits US plane wave (blue lines). Plane wave is emitted both 
in the forward direction (towards the target) and reverse direction (towards the acoustic lens). In 
Figure 7.1, plane wave emitted in forward direction is shown only. The plane wave was 
backscattered by the target. The backscattered wave (red curves) propagated through the PVDF 
film transducer to be focused by a custom designed acoustic lens (39.8 mm focal length, 32 mm 




12 dB bandwidth: 3MHz – 6.7 MHz, element count:16, pitch: 0.7 mm ). To obtain a 
magnification of -1 between the image plane and the object plane, the object distance i.e. the 
distance between the target and the acoustic lens and the image distance i.e. the distance between 
the acoustic lens and the transducer array were kept equal to  twice the focal length of the 
acoustic lens. The distance between the target and the PVDF film was maintained to be within 
the ‗nearfield region‘, determined by the aperture of the PVDF film and the peak wavelength of 
the input signal driving the PVDF, to ensure that the incident wave on the target remained plane 
wave. The US signal received by the linear transducer array was amplified by the amplifier. The 
amplified US signal was digitized and stored in oscilloscope (Lecroy, WaveRunner 6030). B-
scan images were formed using the stored A-line US signals in the oscilloscope. The US images 
can be directly produced from the acquired data by this setup without any type of receiver beam 
forming or electronic focusing algorithm. Depending on the configuration of the switch, the 
PVDF film was driven either by the pulser (JSR Ultrasonics, DPR 300) to produce a short pulse 
similar to that used in the conventional US pulse echo imaging or by the combination of signal 
generator (Analogic, Polynomial Waveform Synthesizer 2020) and power amplifier (Electronics 
& Innovation, A150)  to produce amplified linear FM signal. To enhance the SNR of the 
backscattered US signal, pulse compression technique was implemented in the above 
experimental set up. The PVDF film transducer was driven by amplified chirp signal with long 
time duration (>10μs) and pulse compression technique was performed in post-processing step 
by cross-correlating the backscattered signal stored in the oscilloscope with input chirp signal. 
As mentioned earlier, the SNR of the compressed pulse is expected to be greater than the SNR of 





Following experiments were performed with the above mentioned imaging system 
 Several US A-line signals were acquired with short duration pulses of different peak to 
peak voltages for a plane reflector target (Aluminum plate) at the object plane. With the 
same target, US A-line signals under chirp excitation with the same set of peak to peak 
amplitudes were also acquired. 
 Two dimensional (2D) point spread function (PSF) of the imaging system was measured 
using a steel wire (0.4 mm diameter) as target in the water tank. Variation of SNR with 
the time-bandwidth product and variation of axial resolution (6dB width along Z axis) 
and lateral resolution (6 dB width along X axis) with the sweep bandwidth of the chirp 
signals have been studied. 
 The above experiments were repeated with three different PVDF films of different 
thickness. Thickness of the three different PVDF films used here were 28 μm (FDT1-
028K, Measurement Specialties), 52 μm (FDT1-052K, Measurement Specialties) and 220 
μm (NDT1-220K, Measurement Specialties).  
 Pulse compressed US A-line signals were acquired with and without the acoustic lens, 
placing the PVDF transducer (US source) at the object plane.  
 Pulse compressed US A-line signals were acquired with pre enhanced amplified chirp 
signal to explore the possibility of bandwidth enhancement. To obtain the pre enhanced 
chirp signal, the PVDF film transducer was driven with an amplitude boost function 








Comparison of SNR obtained after pulse compression with the SNR obtained with conventional 
short pulse: US A-line signals obtained using the plane reflector as target are shown in Figure 7.2 









Figure 7.2: SNR enhancement as a result of pulse compression; (A) Short duration input pulse, 
(B) Output signal recorded by the linear array when the input is A, here the presence of PVDF 
film is visible but the signal due to the plane reflector is completely buried in noise, (C) Input 
chirp signal having 40μs time duration and 8MHz sweep bandwidth, (D) Output signal when the 
input is C (before pulse compression), here the presence of PVDF film is visible and the signal 
due to plane reflector is barely visible, (E) Compressed pulse where the presence of both PVDF 
film and the plane reflector are clearly visible. The input peak amplitude of both the short pulse 




and the chirp signal were 0.25 volts. SNR for the plane reflector signal in E (SNRcompressed) is 
42.4, SNR for the plane reflector signal in D is 1.37 (SNRuncompressed) and SNR for the plane 
reflector signal in B is 0.94 (SNRpulse). The signals marked as PVDF in B, D and E occurred due 
to the plane wave emitted by the PVDF film transducer in the reverse direction (towards the 
acoustic lens in Figure 7.1). 
Comparison of SNR obtained after pulse compression with the SNR obtained with conventional 
short pulse: Figure 7.3 shows the improvement of the SNR values after pulse compression. 
GSNR or gain in SNR of the compressed pulse is the ratio of the SNRcompressed (SNR after 
compression) to SNRuncompressed (SNR before compression). The SNR for an A-line signal was 
calculated by taking the ratio of area under the power spectrum of signal to area under the power 
spectrum of noise. The PVDF film transducer (Measurement Specialties, NDT1-220K) used here 
consists of two layers of 110μm thick films and has 2.3 MHz 6dB bandwidth (1.7 MHz – 4 
MHz). To obtain the compressed pulses, linear FM waves with 40μs time duration and 8 MHz 
sweep bandwidth (0.5MHz – 8.5 MHz) were used. The conventional short pulse imaging was 
done with short pulses having 3MHz center frequency. Figure 7.3 shows SNR of the compressed 






Figure 7.3: Plot of SNR values obtained for the compressed pulse and the conventional short 
pulse against peak input voltages. 
Variation of GSNR/SNRcompressed with chirp signal bandwidth: Figure 7.4 shows the variation of 
SNR values of the compressed pulse, obtained with a plane aluminum reflector as the target, 
with the variation of time bandwidth product i.e. product of time duration (T0) and sweep 
bandwidth (2B) of the input chirp signal. The PVDF film transducer (Measurement Specialties, 
FDT1-028K) used here was 28μm thick. Though not measured, it was expected to have a 
uniform spectrum over a wide frequency range because of its small thickness. Here the sweep 
bandwidth of the input chirp was increased linearly maintaining the center frequency (fc) almost 
the same. Both SNRcompressed and GSNR increase almost linearly with the increase of the time 
bandwidth product. For time bandwidth product greater than 250, the GSNR remains constant 
which may have happened due to the finite bandwidth of the receiving US transducer array 
(12dB bandwidth: 3 MHz – 6.7 MHz). The SNR values obtained before and after pulse 






Figure 7.4: Plot of GSNR and SNRcompressed for the compressed pulses against the time bandwidth 
product of the input chirp signals. 
Variation of Axial and Lateral resolution with chirp signal bandwidth: Table 7.1 lists axial and 
lateral resolution of this imaging system as well as the SNR values obtained after pulse 
compression with different input chirp signals. Figure 7.5A and 7.5B show the variation of axial 
resolution (6dB width of the point spread function along Z [Figure 7.1] axis) and lateral 
resolution (6 dB width of the point spread function along X [Figure 7.1] axis) with different 
sweep bandwidth of the input chirp signal respectively. Figure 7.6 shows the two dimensional 
point spread function in X-Z plane for a particular case in Table 7.1 and the corresponding axial 
and lateral resolution. Axial and lateral resolutions for different chirp signals were measured 
using the steel wire as the target. The PVDF film transducer (Measurement Specialties, FDT1-









Table 7.1: Axial resolution, lateral resolution and SNR values before and after pulse compression 
for different input chirp signals. The PVDF film transducer (Measurement Specialties, FDT1-
028K) used here was 28μm thick. 
 












[Plane reflector target] 
20μs/5MHz/4 MHz  0.56  1.2  1.63/46.7/28.64 
25μs/5MHz/5MHz 0.51  1.2  2/95.71/47.77 
30μs/5MHz/6MHz 0.49 1.3  1.67/269.46/162.48 
35μs/5MHz/7MHz  0.44  1.3  1.9/464.39/243.83 






Figure 7.5: Plot of axial and lateral resolution against sweep bandwidth of the input chirp signal. 
(A) Axial resolution vs sweep bandwidth (B) Lateral resolution vs sweep bandwidth. 
Figure 7.5A shows that axial resolution improves almost linearly with the sweep bandwidth of 
the input chirp signal up to a certain limit (7 MHz) and then it remains constant. The upper limit 
of the axial resolution may have occurred due to the finite bandwidth of the receiving transducer 
array. Figure 7.5B shows that lateral resolution remains almost constant with the variation of the 








 Figure 7.6: Two dimensional point spread function of the imaging system after pulse 
compression for an input chirp signal of sweep bandwidth 4 MHz and time duration 20μs; (A) 
2D PSF (X-Z plane) displayed in purely logarithmic scale; (B) Lateral cut (along azimuthal/X 
axis) of the 2D PSF in A, the 6dB width is 1.2 mm; (C) Axial cut (along Z axis/time axis) of the 
2D PSF in A, 6dB width is 0.56 mm/0.36 µs.   
To examine whether the acoustic lens would alter the quadratic phase relationship of the input 
chirp signal, we performed pulse compression both in presence as well as in absence of the 
acoustic lens. Here, we did not use any target. The acoustic lens was placed in between the 
PVDF film and the transducer array in such a way that the lens was separated by equal distances 
from both of the US transducers. The PVDF film was driven by amplified long duration chirp 
signal [20 µs long and 4MHz sweep bandwidth] and the emitted US plane wave was received 
directly by the transducer array. The compressed pulse was obtained by cross correlating the 
input chirp used to drive the PVDF film and the output signal received by the transducer array. 
The same experiment was repeated without the acoustic lens. The PVDF film transducer 





Figure 7.7: Pulse compression in presence of the acoustic lens (A) input chirp signal of 20 µs 
time duration and 4 MHz sweep bandwidth (B) output chirp signal received by the transducer 
array (C) Phase spectrum of input and output chirp signals (D) Amplitude spectrum of the input 




correlation between A and B. 
 
Figure 7.8: Pulse compression in absence of the acoustic lens (A) input chirp signal of 20 µs time 
duration and 4 MHz sweep bandwidth (B) output chirp signal received by the transducer array 
(C) Phase spectrum of input and output chirp signals (D) Amplitude spectrum of the input chirp 
(E) Amplitude spectrum of the output signal (F) Compressed pulse as a result of cross correlation 
between A and B.  
Figure 7.7 and Figure 7.8 show the results of the pulse compression experiments performed with 
and without the acoustic lens in between the source and receiver transducer. For both the cases, 
pulse compressions were successfully performed, as seen by the enhanced SNR and short time 
durations of the compressed pulses. To examine whether the acoustic lens alters the phase 
relationship of the chirp signals, the phase spectra of the input and the output chirp signal were 
plotted for both the cases [Figure 7.7C and Figure 7.8C]. It is visible that, for both in presence 




from Figure 7.7D and Figure 7.8D] the output phase spectrum followed the input phase spectrum 
without any major change. This proves conclusively that presence of the acoustic lens does not 
alter the quadratic temporal phase of the linear FM signal during its passage through the lens. 
The preliminary results show that a PVDF film transducer can be used as an US transmitter in 
the acoustic lens focusing based US imaging system. This study demonstrates that the acoustic 
lens does not alter the quadratic phase relationship of the chirp signal. Consequently the focused 
chirp signal can be compressed into a short pulse with cross correlation processing. The SNR 
enhancement due to pulse compression depends upon the time duration, swept bandwidth of the 
input chirp signal and the frequency spectrum of the US transducers. Since two separate US 
transducers have been used here as US source and receiver, significantly long duration chirp 













7.7 Additional Results & Images 
Table 7.2: Axial resolution, lateral resolution and SNR values before and after pulse compression 



















[With wire target] 
20μs/5MHz/4 MHz  0.63  1.5  89/1018/11.43 
25μs/5MHz/5MHz 0.61  1.5  102.45/1100/10.73 
30μs/5MHz/6MHz 0.58 1.5  103.7/953/9.19 
35μs/5MHz/7MHz  0.53  1.4  100/1927/19.27 
40μs/4.5MHz/8MHz 0.51 1.6  118.5/940.4/7.94 




Table 7.3: Axial resolution, lateral resolution and SNR values before and after pulse compression 


























[With wire target] 
20μs/5MHz/4 MHz  2.18  2.1  149/648/11.43/4.35 
25μs/5MHz/5MHz 1.52  2.4  140/721/5.15 
30μs/5MHz/6MHz 1.40 2.2  181/605/3.34 
35μs/5MHz/7MHz  1.31  2.3  144.4/2793/19.34 
40μs/4.5MHz/8MHz 1.32 2.3  241/2515/10.43 





Figure 7.9: Actual experimental set up [Block diagram shown in Figure 7.1]  (A) Different 
components in the water tank (B) The complete set up. The function generator generates the 
signal which after being amplified by the power amplifier, is used to drive the PVDF film to 
generate ultrasound wave. The backscattered ultrasound wave from the object as well as the part 
of ultrasound wave generated by the PVDF film which moves in opposite direction than the 
object are received by the 1D array through the acoustic lens and converted to a time dependent 











CHAPTER 8: Discussions, Conclusions & Future work 
8.1 Discussions and Conclusions 
8.1.1 PA Image Analysis 
In this study, PA image analysis was performed retroactively on the ex vivo multiwavelength PA 
images of excised human prostate and thyroid specimens. The aim of the study was to identify 
malignant, benign and normal tissue using extracted features from the acquired PA images. 
Special emphasis was given on differentiating malignant tissue from nonmalignant tissue. The 
prostate specimens were obtained from patients who underwent biopsy confirmed prostatectomy 
and the thyroid specimens were obtained from patients who underwent thyroidectomy because of 
suspected thyroid lesion. Multiwavelength PA images were acquired immediately after surgery. 
Histopathologists marked the ROIs corresponding to malignant, benign and normal on the 
histology slides. Digital images of the histology slides were used as ground truth to select ROIs 
in the 3D PA data. 
Spatially varying chromophore concentration of tissue, extracted from multiwavelength PA 
images, provides physiological information about the tissue. Measuring the concentration of 
particular chromophores, specific tissue pathologies like malignancy can be identified. But the 
inverse problem involving quantitative recovery of the chromophore concentrations from PA 
images is extremely difficult due to factors like absorption and scattering of light inside tissue. 
This makes tissue characterization, solely based on chromophore concentration, very difficult. In 
this study, we decided to extract additional features, as many as possible, from the PA data and 




differentiation of malignant tissue from nonmalignant tissue. This way the additional features 
would augment the capability of tissue characterization. 
2D C scan PA image pixel values depend on the PA signal amplitude at a particular time instant 
or summation/mean/maximum of the PA signal amplitudes acquired over a very small time gate. 
Therefore, for the chromophore concentration estimation, the PA image signal at any particular 
time instant or over a very short time gate is used. Neither chromophore concentration nor C 
scan PA image pixel values directly depend on the temporal features of the RF PA signals. The 
temporal features of the time dependent PA signal depend on the shape and size of the particular 
PA absorbers. Evidence for this has been demonstrated via simulation in Chapter 5. We 
hypothesized that between malignant and nonmalignant tissues, PA absorbers i.e. the sites of PA 
wave generation, differ in shape and size and these differences will be manifested in the temporal 
features of the RF PA signals. As the spectrum and time domain features of the RF PA signal are 
correlated, analysis of PA spectrum can potentially give useful information about the structural 
change of PA absorbers between different tissue pathologies. We decided to analyze the 
spectrum of time dependent PA signals belonging to different tissue pathologies. To obtain a 
clear idea about the distinctive temporal features and frequency content of PA signal generated 
by different shaped PA absorbers, we modeled PA signals due to spherical, cylindrical and thin 
film shaped absorbers. We extracted a number of features from ROIs of importance, selected 
from the acquired 3D PA data of the excised human prostate and thyroid specimens. For 
selecting the ROIs, digital images of the marked histology images were used as ground truths. 
The extracted feature can be divided broadly into three different categories namely a) 
multiwavelength PA pixels [PA pixels at 760 nm, 800 nm, 850 nm, 930 nm and 970nm] b) 




frequency parameters [slope, midband fit, intercept and spectral centroid at 760 nm, 800 nm, 850 
nm, 930 nm and 970 nm]. Prior to extraction of the frequency parameters, we did an extensive 
simulation study to find out the limitations and applicability of the frequency analysis technique 
for our limited bandwidth PA acquisition system. Once the parameters/features were extracted, 
statistical analysis was performed to find out whether they are significantly different between 
different tissue pathologies. Here, as differentiation of malignant tissue from nonmalignant tissue 
was the primary objective of this study, a new tissue category ‗nonmalignant‘ was introduced in 
which benign and normal tissue data were stacked together. For prostate tissue, only 5 [PA pixel 
value at 930 nm, water concentration, slope at 930 nm and spectral centroid at 930 nm and 970 
nm] out of a total of 29 features were not significantly different between malignant and 
nonmalignant tissue, whereas for thyroid the number of parameters which were not significantly 
different between malignant and nonmalignant tissue was also 5 [slope at 760 nm, 800 nm, 850 
nm, 930 nm and 970 nm]. Between malignant and normal tissue the number of parameters not 
significantly different was 5 [PA pixel value at 930 nm, water concentration, slope at 930 nm and 
970 nm, spectral centroid at 970 nm] for prostate tissue and 4 [slope at 760 nm, 850 nm, 930 nm 
and 970 nm] for thyroid tissue. For malignant vs. benign tissue, 8 [PA pixel value at 800 nm, 
oxyhemoglobin and lipid concentration, slope at 800 nm, intercept at 760 nm and 970 nm, 
spectral centroid at 800 nm and 850 nm] out of 29 parameters were not significantly different for 
prostate tissue and 8 [oxyhemoglobin, lipid and water concentration, slope at 800 nm, 850 nm, 
930 nm and 970 nm, spectral centroid at 760 nm] out of 29 parameters were not significantly 
different for thyroid tissue. As far as benign vs. normal tissue is concerned, for prostate 7 [water 
concentration, slope at 760 nm, 850 nm, 930 nm and 970 nm, intercept at 930 nm, spectral 




number of parameters not significant different were also 7 [PA pixel value at 970 nm, slope at 
970 nm, midband fit at 970 nm, intercept at 760 nm, 800 nm and 970 nm, spectral centroid at 
970 nm]. 
Multidimensional dataset were built with the extracted features from prostate PA data and 
classification algorithms were applied on them to predict malignant and nonmalignant prostate 
tissue. The process in which classification algorithms like ANN, SVM etc. are employed for 
detection and diagnosis of the suspected disease is known as CAD. As classification algorithms 
can process a large number of markers simultaneously and they can model non-linear 
relationship between inputs and outputs, the limited decision making abilities of human beings 
can be improved by CAD. In this study, using SVM and ANN, the ability of the extracted 
features to predict malignant and nonmalignant prostate accurately was tested. ANN with a 
particular architecture, which was found to produce the best prediction of malignant as well as 
nonmalignant prostate tissue using the complete 29 dimensional feature space, was used to 
compare the performance of features belonging to different categories. Frequency parameters i.e. 
parameters extracted from PA spectrum, performed best in differentiating malignant from 
nonmalignant tissue [sensitivity and specificity with testing dataset are 85% and 84%]. 
Performance of combination of all the features [29 dimensional feature space] was better than the 
performance of the frequency parameters alone [sensitivity and specificity with testing dataset 
are 93% and 91%]. 
This study shows that parameters extracted from PA spectrum are significantly different between 
malignant and nonmalignant tissue type for human prostate and thyroid tissue. From the results 
of this study it is evident that the frequency parameters alone can be used in a suitable CAD 




study has also shown that when parameters belonging to all the categories used together, the 
accuracy of the malignant prostate tissue prediction become highest. 
As mentioned in Chapter 1 [Section 1.2], this study has intended to fill specific gaps in the field 
of PA imaging for cancer detection. Those specific gaps have been filled in the following manner 
 A large scale study, in which frequency domain parameters extracted from ex vivo 
multiwavelength PA image data was used to differentiate between malignant, benign and 
normal tissue, was performed involving 30 prostate cancer patients and 20 thyroid cancer 
patients. 
 Time domain and frequency domain PA features were combined to form a 
multidimensional feature space which was applied to a suitable CAD system for prostate 
cancer diagnosis. 
 Using the same CAD system, performances of time domain PA features were compared 
with that of frequency domain PA features for prostate cancer diagnosis. 
8.1.2 Pulse echo US Imaging System 
PA imaging does not provide the required anatomical cues to localize the position of the detected 
lesion. For image guided diagnostic and therapeutic procedures, accurate localization of the 
detected lesion is of utmost important. For example, in image guided needle biopsy for prostate 
cancer diagnosis, accurate positioning of the malignant tumor is not only essential for directed 
sampling but it is also very important for providing positional feedback of the needle tip relative 
to the lesion, based on which the needle tip coordinates can be corrected in real time. Although 
sensitivity and specificity of US imaging for diagnosis of prostate cancer lesions is low, it can 




coregistered PA and US image, it is possible to detect as well as localize cancer lesions with high 
accuracy. In this study, we developed a novel pulse echo US imaging system which is 
compatible with our existing PA imaging system. As we incorporated acoustic lens based 
focusing in our US imaging system, a separate US source and receiver were needed to be used 
here. Keeping in mind that the US imaging system would be integrated with our existing PA 
imaging system in the future, we chose the US source in such a way that its interference to the 
PA and US wave coming out of the soft tissue, would be minimal. A PVDF film transducer, 
because of its flexibility, low acoustic impedance mismatch with water and small thickness, was 
chosen as the US source. As PVDF film does not transmit high intensity US wave, the SNR of 
the received US wave was anticipated to be low. To improve the SNR, pulse compression 
technique was implemented in this system. We verified that the pulse compression technique can 
be implemented in presence of the acoustic lens. SNR enhancement due to pulse compression 
was observed. We measured the 2D PSF of the imaging system in a water bath. As the receiver 
transducer array used in this imaging system is similar to that used in the PA imaging system 
along with the similar acoustic lens focusing based technology, we expect that this US imaging 
technology can be easily incorporated to our existing PA imaging probe. 
The results of this study show that PVDF film can be successfully used as US transmitter and 
pulse compression technique, even in presence of acoustic lens, can be used to enhance SNR of 







8.2 Future Works 
8.2.1 PA Image Analysis: 
For quantitative feature extraction like absolute optical absorption coefficient recovery or 
chromophore concentration recovery, optical absorption and scattering inside the soft tissue and 
their nonlinear relationship with laser fluence distribution in the soft tissue has to be considered 
in detail. In this study, we worked with ex vivo PA images of thin [2 – 3 mm] tissue specimens 
and we hypothesized that the laser light fluence will not vary in XY plane severely because of 
small tissue thickness. We incorporated 1D light attenuation model to correct for the light 
attenuation effect only along Z axis, considering that the optical properties of specimens remain 
the same along the depth. For in vivo mage analysis or ex vivo imaging with thick tissue 
specimens, a detailed 3D model based or experimental observation based correction scheme for 
optical attenuation should be incorporated. There is no standardized correction scheme that can 
be applied to all the PA imaging configurations. Still, prior to doing any quantitative analysis 
with in vivo PA images, a detailed 2D/3D correction scheme, that will be appropriate for the 
particular PA imaging configuration, should be implemented. Although the number of 
features/parameters, extracted from multiwavelength PA data of the excised human specimens 
was quite high, a few different approaches can be undertaken to extract some additional number 
of features. For example, selecting a suitable mother wavelet, continuous wavelet transform 
(CWT) of the PA signals can be computed and then wavelet coefficients corresponding to 
instantaneous peak frequency and time can be extracted corresponding to ROIs belonging to 
different tissue pathologies. Registration for ROI selection in the 3D PA data can be made 
automatic for increasing the ROI selection accuracy. The automatic registration process has to be 




marked histology slide followed by registration between the digital specimen image and the 2D 
C-scan PA image] and in developing it, all the difficulties mentioned in chapter 3 have to be 
considered. 
8.2.2 US imaging system 
The immediate future work with the US imaging system is to incorporate the US imaging 
technology in the existing PA imaging probe and test the performance of the dual mode imaging 
probe with phantoms and soft tissue specimens. This includes experiments with specially 
designed phantoms to test how well the PA and US images acquired by the dual mode probe are 
registered. Once the SNR of US images and registration between US and PA images are 
satisfactory, additional measures/modifications can be implemented to enhance the performance 
of US imaging. Axial resolution improvement and side lobe reduction are two important 
performance enhancement factors to consider. Hardware realization of post processing works 
related to pulse compression technique is another important factor to consider seriously as the 
near real time imaging capability of the dual mode imaging probe depends on it. 
8.3 Impact  
The image analysis framework developed in this study has shown that multiple features can be 
extracted from multiwavelength 3D PA data generated by soft tissue and the features can be used 
in a suitable CAD system for effective diagnosis of malignant tissue. Incorporating a suitable 
correction scheme for wavelength dependent, nonlinear distribution of light fluence inside soft 
tissue, this image analysis framework can also be applied to multiwavelength PA images 
acquired in vivo. This technology is not limited to any specific organ or disease or PA imaging 




disease, be it cancer, coronary artery blockage or anything else and the PA image configuration 
be it PAT or PAM, as long as 3D PA data can be acquired, this image analysis technology can be 
applied to the data. Exogenous contrast agent based PA imaging is becoming increasing popular. 
This image analysis technology can be potentially used to augment the abnormality detection 
capability of contrast agent based PA imaging. As it is a post processing technology, it does not 
require any new hardware and the required software can be built using any of the widely 
available packages like Matlab, C++ or Python. 
As mentioned in Chapter 2, imaging technology with high sensitivity and specificity is required 
for accurate prostate cancer diagnosis and management. Although the number of patients 
considered for this study is small and this was an ex vivo study, the results of this study are 
promising. This may inspires researchers to undertake large scale in vivo PA imaging of prostate 
cancer with CAD system. 
This study has found that the parameters extracted from the frequency domain of PA signals can 
play a significant role in tissue characterization. Power spectrum analysis, which is a proven 
technology for tissue characterization in US imaging, is not a well researched domain in the case 
of PA imaging. For example, no one has tried to find out if analytical relations exist between the 
spectral parameters and the shape and size of PA microabsorbers. Findings of this study may 
inspire researchers to undertake further studies for acquiring a better understanding of the power 
spectral parameters extracted from PA signals. 
The dual mode imaging system, that can be developed by incorporating the novel US imaging 
technology developed in this study into the existing ex vivo PA imaging probe, will be able to 




PA imaging probe is an ex vivo imaging probe, it has been designed in such a way that after 
incorporating a proper laser light delivery system, it can be used as in vivo transrectal PA and US 
imaging probe for prostate imaging. The US imaging technology has been developed in such a 
way that it can be incorporated in the in vivo imaging probe. The dual mode PA and US imaging 
probe will potentially detect as well as localize malignant tissue with high accuracy. In addition 
to prostate cancer imaging, the dual mode imaging probe can also be used for in vivo PA 
imaging of breast, thyroid and skin. The US imaging technology developed in this study has 
successfully used PVDF film as US transmitter and implemented pulse compression technique 














APPENDICES: ADDITIONAL WORKS 
A.1 Cepstrum Simulation 
From 1D time dependent PA signal simulations [Chapter 5], it has been observed that the PA 
spectra generated by different PA absorbers contain periodic/quasiperiodic structures. As the PA 
frequency spectra depend on the shape and size of PA absorbers, we assumed that quantitative 
information about the dimension of the PA absorber could be extracted from the 
periodic/quasiperiodic structure of the PA absorbers. In Chapter 5, we fitted linear models to the 
PA power spectrum within usable bandwidth to extract information from PA spectra. Here, we 
thought of applying cepstrum analysis to characterize the periodicity of the PA spectra and 
thereby getting information about the size of the PA absorber. In addition to the inherent periodic 
nature of the PA spectra, presence of more than one PA absorbers along the depth inside a ROI 
give rise the high requency ripple in the resultant frequency spectrum of the PA A-line signal. 
This high frequency ripple can also be characterized by cepstrum analysis to find out the distance 
between the successive absorbers along the depth. Using a phantom study, Gertsch et al. 
experimentally demonstrated that diameter of single cylindrical absorber can be determined from 
the quefrency corresponding to the cepstrum peak of the PA signal generated by the absorber 
[A.1]. Here, we performed a simulation study to observe the relationship between the cepstral 
peaks and the dimensions of different PA absorbers. 
If a time dependent signal z(t) can be expressed as convolution of x(t), the basic wavelet and e(t) 
a high frequency time dependent signal, then cepstral analysis can be used to express z(t) as the 
sum of two signals.  
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The Cepstrum of a data sequence is obtained by taking the IDFT (inverse discrete Fourier 
transform) of the logarithm of the magnitude of the DFT (discrete Fourier transform) of the data 
sequence. Figure A.1 describes the three steps involved in calculating the cepstrum of a data 
sequence. 
 
Figure A.1 Cepstrum Analysis 
If, Z(n), E(n) and X(n) be the Fourier transforms of z(t), e(t) and x(t), then  
                                                       )()()( nXnEnZ                                                                A.2 
Taking logarithm of the magnitude of the Fourier transforms, we get 
                                             
     )(log)(log)(log nXnEnZ                                              A.3   
Now, if the IDFT is taken of both sides of equation A.3, then 
                                                          )(ˆ)(ˆ)(ˆ txtetz                                                                  A.4   
Where )])([log()(ˆ nZIDFTtz   , )])([log()(ˆ nEIDFTte   and )])([log()(ˆ nXIDFTtx   
The logarithm of the spectrum of z(t) can be imagined as a waveform with some form of 
amplitude modulation. Here, the logarithmic amplitudes of the ripple introduced by e(t), will be 
modulated by log(X(n)). These two components can be separated by taking the inverse Fourier 
transform, as shown in Equation A.4. After taking the inverse Fourier transform, the signal will 
be transformed into time domain, but since the logarithm of the spectrum in Equation A.3 has 
been treated as a waveform, so the independent variable in Equation A.4 will be considered as a 




‗quefrency‘ and the signal obtained in Equation A.4 is named as ‗cepstrum‘. The cepstrum will 
contain a large peak due to the ripple and some other peaks due to the amplitude modulation i.e. 
the basic wavelet. Now, if the ripple and the basic wavelet occupy different quefrency ranges, 
then they can be separately retrieved by ‗liftering‘ in the quefrency domain which is equivalent 
to filtering n the frequency domain [A.2, A.3].  
Figure A.2: Simulated PA amplitude spectrum and cepstrum for spherical PA absorber (A) 
Normalized amplitude spectrum generated by a spherical PA absorber of radius 0.5 mm (B) 
Logarithm of PA amplitude spectrum in Figure A.2A (B) Cepstrum plot of the PA signal 
generated by a spherical PA absorber of radius 0.5mm (D) Normalized amplitude spectrum 
generated by two spherical PA absorbers separated by 7 mm along depth/Z axis and each of 
radius 0.5 mm (E) Logarithm of PA amplitude spectrum in Figure A.2D (F) Cepstrum plot of PA 
signal generated by two spherical PA absorbers separated by 7 mm along depth/Z axis and each 




Figure A.2 shows the simulated amplitude spectrum and cepstrum plots of the PA signal 
generated by spherical absorbers. While the upper column [Figure A.2A-C] shows spectrum and 
cepstrum due to a single PA absorber, the lower column show similar plots for PA signal 
generated by two identical spherical PA absorbers arranged along Z axis at a distance 0.7 mm 
from each other. The solid black arrow in Figure A.2C shows the primary cepstral peak 
corresponding to the radius of the PA absorber. As it can be seen from Figure A.2A and also 
from Equation 5.16, the minima in the PA amplitude spectrum are not exactly periodic. We 
assume that is the reason why the primary cespstral peak at quefrency 0.69 µs in Figure A.2C 
does not exactly correspond to the theoretical location of the cepstral peak [0.64 µs] 
corresponding to the radius of the sphere. In case of two similar PA absorbers separated by a 
certain distance along Z axis, high frequency ripples appear in the PA amplitude spectrum as 
seen in Figure A.1D. These ripples manifest a secondary cepstral peak indicated by the broken 
arrow in Figure A.2E. The quefrency corresponding to the secondary cepstral peak is 4.543 µs 




Figure A.3: Simulated PA amplitude spectrum and cepstrum for cylindrical PA absorber (A) 
Normalized amplitude spectrum generated by a cylindrical PA absorber of radius 0.5 mm (B) 
Logarithm of PA amplitude spectrum in Figure A.3A (B) Cepstrum plot of the PA signal 
generated by a cylindrical PA absorber of radius 0.5mm (D) Normalized amplitude spectrum 
generated by two cylindrical PA absorbers separated by 7 mm along depth/Z axis and each of 
radius 0.5 mm (E) Logarithm of PA amplitude spectrum in Figure A.3D (F) Cepstrum plot of PA 
signal generated by two cylindrical PA absorbers separated by 7 mm along depth/Z axis and each 
of radius 0.5 mm.  
Figure A.3 shows the simulated amplitude spectrum and cepstrum plots of the PA signal 
generated by cylindrical absorbers. While the upper column [Figure A.3A-C] shows spectrum 
and cepstrum due to a single PA absorber, the lower column show similar plots for PA signal 
generated by two identical cylindrical PA absorbers arranged along Z axis at a distance 0.7 mm 




the radius of the PA absorber. The quefrency corresponding to the cepstral peak indicated by the 
arrow in Figure A.3C is 0.67 µs. In case of two similar PA absorbers separated by a certain 
distance along Z axis, high frequency ripples appear in the PA amplitude spectrum as seen in 
Figure A.3D. These ripples manifest a secondary cepstral peak indicated by the broken arrow in 
Figure A.3E. The quefrency corresponding to the secondary cepstral peak is 4.527 µs. 
 
Figure A.4: Simulated PA amplitude spectrum and cepstrum for a thin film PA absorber (A) 
Normalized amplitude spectrum generated by a thin film PA absorber of thickness 0.5 mm (B) 
Logarithm of PA amplitude spectrum in Figure A.4A (B) Cepstrum plot of the PA signal 
generated by a thin film PA absorber of thickness 0.5mm  
Figure A.4 shows the simulated amplitude spectrum and cepstrum plots of the PA signal 
generated by cylindrical absorbers. The solid black arrow in Figure A.4C shows the primary 
cepstral peak corresponding to the thickness of the thin film PA absorber. The quefrency 





A.2 Photoacoustic Microscopy System 
A Photoacoustic Microscopy [PAM] system has been developed in our laboratory to acquire 
high resolution PA image data generated by small and thin tissue samples.  
Figure A.5: Block diagram of the PAM system. 
Figure A.5 shows the block diagram of the PAM setup developed in our laboratory. Fiber optic 
cable or fiber bundle delivers pulse laser light from the Q-switched Nd-YAG laser (Wavelength: 
1064 nm, Pulse Repetition Frequency: 10 Hz, LPU 250, Litron Laser) on the sample held by the 
sample holder. PA waves generated by the sample after absorbing laser light, are collected by a 
single element high frequency focused transducer. The transducer is connected to one of the 
eight channels of the variable gain preamplifier (Texas Instruments VCA8500EVM). The 
VCA8500 board is capable of producing a maximum gain of 50 dB (20 dB pre amplification 
gain combined with a selectable post gain amplification of 20/25/27/30 dB) along with a choice 




contains an eight channel National Instruments (NI) PXI-5105 high speed digitizer in a NI PXI-
1033 chassis. After firing each pulse, the laser provides an output trigger signal to the PXI 
chassis for synchronization between the laser and DAQ system. The sampling frequency of the 
digitizer is 60 MHz with 12 bit resolution. The PXI-5105 provides a 16 MB onboard memory 
buffer in which the digitized PA signals are stored temporarily. The PXI chassis containing the 
digitizer is connected to the computer where the digitized PA signals are transferred via MXI 
interface. The sample holder is held by an assembly of two translational stages (Zaber 
Technologies Inc.) which are controlled by two linear actuators (Zaber Technologies Inc.). The 
translational stages move the sample holder along X and Y axis to enable the raster scanning of 
the sample by the stationery transducer element in the cross sectional plane. The complete data 
acquisition and the scanning procedure is controlled by a Labview based software [A.4]. The 
stored PA signal values are processed by a custom designed Matlab based software for 
generating corresponding C scan and B scan PA images. For this setup, the lateral resolution of 
the PA image depends on the focused beam diameter of the single element transducer. For 
improving lateral as well as axial resolution, a high frequency focused transducer (50 MHz 











Figure A.6 shows the actual experimental setup for the PAM system. 
Figure A.6: Experimental setup of the PAM system. 
A.3: Modeling of Light Distribution in Soft Tissue 
For quantitative PA imaging, implementation of a suitable correction scheme for excessive light 
attenuation inside soft tissue is of utmost importance. The ideal correction scheme should be 
based solely upon experimental observation of light distribution inside soft tissue. As that would 
require dedicated hardware along with excessive time, researchers often try to build correction 
schemes based on 2D/3D models for light transport inside soft tissue. Here we modeled pulse 
laser light distribution inside excised prostate tissue using Monte Carlo method. Values of the 





A.3.1 Monte Carlo Modeling  
Monte Carlo method consists of a stochastic model in which the value of a physical quantity is 
determined by computing the average of the independent samples of a certain random variable. 
The independent samples of the random variable are chosen randomly from the probability 
distribution of the variable [A.6]. We used MCML along with CONV, standard C language 
based tools developed by Wang et al. [A.7, A.8] for modeling steady state light transport through 
multi layered tissue using Monte Carlo method for simulating laser light distribution inside 
excise prostate tissue.  
Figure A.7: Absorbed laser light energy distribution inside excised prostate tissue (A) Absorbed 
laser energy in a RZ plane in dB scale (B) Absorbed laser energy in J/cm
3
 at different values of Z 
for R = 0 (C) Absorbed laser energy vs. R for Z = 0.5 cm. 





Figure A.8: Laser light Fluence distribution inside excised prostate tissue (A) Laser Fluence in a 
RZ plane in dB scale (B) Laser Fluence in J/cm
2
 at different values of Z for R = 0 (C) Laser 
Fluence vs. R for Z = 0.5 cm. 
Figure A.8 shows the laser fluence distribution inside an excised prostate tissue specimen. Both 
absorbance and fluence were modeled modeled using MCML and CONV. 
For generating absorbance as well as the fluence plots, the following parameter values were 
used. 
µa = 0.6 cm
-1
, µs = 100 cm
-1
, g = 0.94. [Optical properties of excised normal human prostate 
tissue at 850 nm] 
The incident pulse laser beam had Gaussian intensity profile, 0.5 cm beam width and 20 mJ per 
pulse input energy. 
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